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Background: Osteoarthritis (OA) is one of the most common musculoskeletal conditions (MSCs) 
worldwide, most commonly affecting those over 60 years of age. OA is associated with pain and 
disability, and also has negative social and emotional effects on the individual. End stage 
management for OA of the knee, when the individual is no longer receiving adequate relief from 
conservative measures, is total knee arthroplasty (TKA). Long waiting lists are a challenge globally 
and in South Africa (SA) where patients often have to wait years to receive their surgery. Evidence 
suggests that the longer an individual is in pain, the more likely they are to stay in pain and thus long 
waiting lists may result in poor post-operative outcomes. It has been found that 10-34% of patients 
undergoing TKA do not gain adequate relief from surgery. Literature suggests that self-management 
interventions using exercise and education are effective in reducing pain and improving function in 
patients who are on a waiting list, in a South African context. The current literature on self-
management programmes does not include post-operative follow-up and thus the current study was 
warranted to determine the effects of a six-week pre-operative physiotherapist-led exercise and 
education intervention on post-operative recovery in patients with OA undergoing total knee 
replacement. 
Methods: A single-blind randomized controlled trial was conducted at Tygerberg Hospital (TBH) in 
the Western Cape, SA. Pain was the primary outcome measure, with disability (WOMAC), health-
related quality of life (EQ-5D-5L), fear of movement (TSK) and function (ALF) as secondary outcomes. 
Participants were randomly placed into the experimental or control group. The experimental group 
took part in a six-week, group programme, which they attended at TBH. Classes were two hours long 
and consisted of education, exercise and relaxation training. The control group’s management 
remained unchanged and they received their usual care. Measurements were taken at recruitment, 
post-intervention, pre-operatively, post-operatively, and at six weeks and three-months post-
operatively by a blinded research assistant. Analysis was by intention to treat. Due to the small 
sample size, non-parametric analysis was conducted and results are presented as median and range 
throughout. Effect sizes were calculated with a 95% confidence interval. 
Results: There were no significant changes between groups on the primary outcome measure of 
pain. The only outcome revealing any significant change between groups was the TSK, with a large 
effect size of 1.39 (0.41 – 2.26 95% CI), indicating that the experimental group performed better 
than the control group at three months post-operative follow-up. 
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Conclusion: Participation in the intervention provided no significant benefit to the experimental 
group over the control group and did not change post-operative outcomes. There were challenges 
with regard to participation and completion of the measurement tools used, raising questions 
regarding issues of pain and fear, self-efficacy, social learning, social cohesion and behavior change. 
The suitability of this intervention for use in a pre-operative population for post-operative benefits, 
needs to be reviewed;  it would appear that what is suitable for those on a waiting list, with no 
clarity on when surgery will occur, may not necessarily apply to those who are actually due  to 
undergo surgery. Future research should consider modifying the intervention, including information 
appropriate to pre and post-operative needs of the population. The roles of self-efficacy, social 
cohesion and social learning in behavior change should be considered and, levels of self-efficacy and 
fear of movement beliefs assessed prior to randomization, in order to adequately establish the 
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Glossary of Terms 
 
Acupuncture: A technique used in Eastern medicine where needles are inserted into the patient's  
skin and muscles. 
 
Ageing index: A calculation used to indicate the rate at which a population is ageing. 
 
Allodynia: Feeling pain when receiving a stimulus which does not usually produce pain. 
 
Apartheid: The system of rule used by the previous government in South Africa. The literal meaning  
is separateness, and it was a system of racial discrimination. 
 
Arthroplasty: Joint replacement surgery. 
 
Arthroscopic debridement: Minimally invasive surgery to remove damaged tissue from a joint. 
 
Assistive device: A tool used to help an individual to perform a required function (walking sticks, 
braces, canes, crutches). 
 
Balneotherapy: Immersion in baths containing mineral water. 
 
Biosychosocial: An approach or framework taking into account the biological, psychological and  
social aspects of a person and their experience. 
 
Biopsychomotor: An approach to pain, viewing behaviour as critical to the experience, rather than a 
by-product of it.  
 
Central sensitisation: “an amplification of neural signalling within the central nervous system that 
elicits pain hypersensitivity” [1]. 
 
Central nervous system: The brain and spinal cord 
 




Chronic pain: Pain that continues beyond normal tissue healing time. 
 
Fear avoidance: The name given to the behaviour associated with negative illness beliefs, resulting 
in avoidance of behaviours which may reproduce symptoms, but may lead to recovery. 
 
Gross domestic product: The total value of production and services in a country for a year. 
 
Group Areas Act: Discriminatory legislation by the Apartheid government which allocated different 
areas for different race groups to live and work in. 
 
Health literacy: An individual's level of ability to gather or receive and comprehend health 
information in order to make decisions regarding their health and use of healthcare services. 
 
Hyperalgesia: Increased pain felt when receiving a usually painful stimulus. 
 
Hypertension: Elevated blood pressure >120/80mmHg 
 
Iatrogenesis: A negative effect on the individual's condition due to the action or interaction with a 
health professional or medical intervention. 
 
Joint lavage: The cleaning out of a joint. 
 
Lower-bound poverty line: Where people are unable to afford sufficient food and non-food items 
because they are too poor. 
 
Musculoskeletal conditions: A range of conditions affecting the body's system of muscles, joints and 
nerves. 
 
Nociceptive/nociception: The stimulation of the nociceptors in the nervous system and the 
response to this stimulation. 
 
Noxious input: Harmful, damaging or dangerous information. 
 




Osteotomy: Cutting into the bone to realign it, by lengthening one side of it. 
 
Peripheral sensitisation: Where nociceptors in the periphery develop increased sensitivity and 
responsiveness following an injury. 
 
Placebo response: A non-specific benefit derived from a treatment or intervention where the 
benefit may be as a result of the expectation of a positive outcome, rather than the specific 
intervention itself. 
 
Rehabilitation: The process of returning an individual to their previous level of function or 
maintaining their function to prevent further disability. 
 
Secondary care: The second level of healthcare in South Africa where more generalised care may be 
received and smaller surgeries performed. 
 
Self-management: Active participation in one's own healthcare and decision-making around that 
care. 
 
Self-efficacy: An individual's belief in their ability to perform the required action to achieve the 
desired result. 
 
Social cohesion: “the willingness of members of a society to co-operate with each other in order to 
survive and prosper”[2]. 
 
Transcutaneous electrical nerve stimulation: An electrotherapy modality commonly used by 
physiotherapists, which provides an electrical impulse into the tissues and can be used to relieve 
pain or stimulate muscle contraction. 
 
Tertiary care: The third level of healthcare in the South African healthcare system. Specialised care 
and big surgeries are performed at a tertiary level. 
 




Total hip arthroplasty: Replacement of both surfaces of the hip joint using prostheses. 
 




 Chapter 1: Introduction 
1.1 Background 
Osteoarthritis (OA) is widely accepted as one of the most common musculoskeletal conditions 
(MSCs) affecting people globally [3-6]. The age-group most affected by the condition are those over 
60 years old [7, 8]. Along with pain, disability is commonly associated with OA [9-11], thus as life 
expectancy increases both globally and within South Africa (SA), one may expect that the burden of 
disease of OA will increase, leading to increased levels of disability. 
OA is a complex condition affecting the patient not just physically, but socially and emotionally as 
well [9, 10]. As such, the management of OA is varied and a number of guidelines have been 
formulated which include conservative strategies, which make use of physiotherapy for 
rehabilitation, education and exercise, as well as surgical measures when non-surgical management 
fails to provide adequate relief [12-16]. Although guidelines for the management of people with OA 
have been put in place, treatment still needs to be individualised to optimise results [17]. 
Joint replacement surgery is indicated for those who no longer respond to conservative 
management [13, 16]. Long waiting lists for joint replacements and delayed surgeries are a problem 
both internationally and within SA in a public health setting where, due to limited resources and 
increasing patient load, patients may wait years to receive their surgery [18, 19]. There is evidence 
to suggest that being on a waiting list affects the individual negatively [19], with long waiting periods 
having the potential to negatively affect post-operative outcomes.  It has also been suggested that 
pain felt by a person in the past, has the ability to affect their functional ability in the future [20]. 
This is problematic in that the public health sector in SA services the majority of the population 
(84%) [21] and as such, a large number of patients are spending many years on waiting lists in pain, 
compromising their post-operative success. 
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Recent studies have investigated the role of the central nervous system in OA pain, and more 
specifically, central sensitisation (CS). Evidence suggests that CS may have a major part to play in the 
chronic pain experienced by people with OA, with about 30% of patients having CS as a component 
of their clinical picture [22, 23]. Although total knee arthroplasty (TKA) has been found to be 
effective in managing patients who do not get the desired relief and functional gains from non-
surgical interventions, not all patients experience positive pain outcomes and persistent pain 
following joint replacement is not unusual [24, 25]. In fact, a systematic review found that 10-34% of 
patients experienced persistent pain following TKA [24]. Unfortunately, the review did not theorise 
as to what the cause of the persistent pain may be. It was noted however, that there is an 
association between better general health, physical, emotional and social function, motivation, self-
efficacy and lower levels of pre-operative pain, and pain in the rehabilitation period, as well as 
better short and medium-term outcomes [24]. 
1.2 Theoretical Framework 
Pain is defined by the International Association for the Study of Pain (IASP) as “An unpleasant 
sensory and emotional experience in response to actual or potential tissue damage” [26]. This 
definition supports the use of a biopsychosocial model of pain which takes into account the 
biological, psychological and socio-cultural factors which influence the pain experience [27]. This 
definition and model will be the reference point when referring to pain throughout this thesis. 
The International Classification of Functioning (ICF) was developed by the World Health Organisation 
(WHO) for use in a variety of applications [28]. It is a useful framework from which to work in both 
research and clinical practice and because it considers aspects of function, disability as well as 
contextual factors [28], it is complementary to the biopsychosocial model of pain. Figure 1 illustrates 
the interactions in the ICF allowing an understanding of the interplay of various factors in the health 











Figure 1: The ICF Framework [28] 
The ICF model is helpful in distinguishing between the differences in impairment of a structure and 
the effect it may have on the individual and their experience of illness. If for example, a patient has 
OA of the knee, the health condition would be OA knee, whilst the impairments may include 
reduced muscle strength and loss of range of motion. The activity influenced by these impairments 
may be walking, which would in turn inhibit the patient’s ability to attend church or whatever other 
social function they may have previously walked to. The patient may feel more comfortable about 
going to church if they could get a lift in a friend’s car, but if there are stairs at church 
(environmental factors) and the patient is scared that they may fall or be sore after climbing the 
stairs (personal factors), they may not attend at all. 
This distinction between aspects relating to the illness experience facilitates the formulation of 
effective treatments which take into account the variety of factors influencing this experience. This 
then allows the health care provider to establish which participation restrictions have meaning for 
the patient and which environmental and personal factors influence these. They can then focus their 
treatments on addressing these aspects specifically. 
  
Personal Factors Environmental 
Factors 




(disorder or disease) 
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Both the ICF framework and the biopsychosocial model of pain are important tools allowing 
researchers and clinicians to formulate complex treatments which facilitate changes in not only 
symptoms, such as pain or reduced range of motion, but more importantly the behaviour of the 
individual. Changing behaviour to facilitate participation and reduce disability is a vital part of a 
successful rehabilitation programme for patients with long standing pain, which is part of the first 
line management of knee OA. The intervention used in this study was previously successfully used in 
people with OA awaiting joint replacement and is grounded in a biopsychosocial framework. It takes 
into account the cognitive (education), physical (exercise and relaxation) and social (group learning) 
factors pertaining to the individual and their illness experience [29]. It also integrates the principles 
of the ICF in that goal setting involves activity and participation, as well as unpacking personal and 
environmental factors influencing the individual’s experience [29]. The current study was designed 
to assess whether an intervention which reduced pain in people with end-stage lower limb OA who 
were on a waiting list for joint replacement, would also improve post-operative outcomes following 
TKA in people with knee OA receiving treatment through the public health sector at Tygerberg 
hospital (TBH), Cape Town, SA. 
1.3 Research Setting 
According to the most recent population data available from the StatsSA 2016 Community Survey, 
there are 55.6 million people living in SA. The majority are black Africans, making up 80.7% of the 
population, followed by Coloured (8.7%), White (8.1%) and Indian/Asian (2.5%). There are 11 official 
languages, with isiZulu (24.6%), isiXhosa (17%) and Afrikaans (12.1%) being the three most 
commonly spoken languages [30]. Education is poor with the majority of people having only a 
primary school level education (81.5%) and 7.1% having had no schooling at all. Service delivery is 
described as inadequate and of the top five challenges identified facing municipalities across SA, four 
were related to poor service delivery, namely: cost of electricity; inadequate housing; lack of safe 
and reliable water supply and inadequate roads [30]. The Community Survey reports that 7.7% of 
the population is disabled, with a sharp increase in disability rates from the 50-54 age group (13.7%) 




One of the many challenges of the Apartheid legacy in SA is a fragmented health system, where 
inequities are common [31]. Although classified as a middle-income country, when comparing SA to 
other middle income nations, its health outcomes are poor [32]. Of the 8.5% of the gross domestic 
product (GDP) spent on health, half of this is spent on the private sector. This leaves 4.25% to be 
spent in the public health sector, which services 84% of the population. 
In 2016, life expectancy for males was 59.7 years and for females 65.1 years. The ageing index in SA 
increased from 23 to 27 between 2001 and 2016, indicating that the population is gradually ageing. 
The province with the highest ageing index was the Western Cape (WC), indicating that there is a 
higher proportion of elderly people compared to the rest of the country [33]. In 2011, 76.2% of 
those 60 years and older were living below the lower-bound poverty line [33]. In 2015 only 22.9% of 
those aged 60 years and older were part of medical aid schemes [33], meaning that the remaining 
77.1% would need to either pay out of pocket for private healthcare, or make use of public health 
services. The three most common medical conditions in the older population were hypertension, 
diabetes and arthritis [33]. Looking at arthritis as one of the most common conditions affecting the 
older population, one may expect that the burden of arthritis to be higher in the WC with a 
significant portion of that burden being managed in the public health sector.  
The composition of the WC population, where the current study is to be conducted, differs slightly 
from that of the rest of the country in that the most commonly spoken languages are Afrikaans, 
isiXhosa and English respectively [30]. Hospitals are overburdened and under-resourced, which 
affects their ability to render services effectively and efficiently [18]. TBH is a tertiary care, public 
hospital in Parow, Cape Town. The hospital primarily provides services to residents of the WC, 
however these services are not exclusive to residents. Patients seen in the Tygerberg orthopaedic 
department are generally referred from surrounding clinics and secondary care facilities for a more 
advanced level of care.  
Therefore, the current study was conducted at TBH, in a population who live in low resource areas 
who probably have low levels of education, live in poverty and are dependent on the public health 
sector for care. The public health sector is also resource constrained and struggles to deliver services 
adequately leading to lengthy waiting lists and systemic challenges to service delivery [18]. It is thus 




1.4 Aims and Objectives 
1.4.1 Aim 
The aim of this study was to determine the effects of a six-week pre-operative physiotherapist-led 
exercise and education intervention on post-operative recovery in patients with OA undergoing total 
knee replacement. 
1.4.2 Objectives 
The objectives were to establish whether participation in a six-week physiotherapist-led exercise and 
education intervention pre-operatively causes a significant change in post-operative outcomes in a 
group of patients undergoing total knee replacement as compared to a control group, with regards 
to the following outcomes: 
1. Pain severity and pain interference [34, 35]. 
2. Disability [36]. 
3. Health related quality of life (HRQoL) [37]. 
4. Function [38]. 
5. Fear of movement [39]. 
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Chapter 2: Literature Review 
2.1. Introduction 
This literature review will begin by examining the current global and local information and statistics 
regarding the epidemiology, prevalence and burden of musculoskeletal conditions, with an emphasis 
on Osteoarthritis (OA). It will seek to discuss aspects related to the appropriate assessment of OA 
and to critically analyse the current management strategies available, according to best practice 
guidelines, as well as related challenges in management, specific to South Africa and health care in a 
government setting. It will conclude by discussing the proposed measurement instruments for the 
current study, according to the objectives, and justify their use. 
2.2 Epidemiology of musculoskeletal conditions 
Musculoskeletal pain is a common problem that most individuals will experience at some point in 
their lives. This pain may be temporary and mild or may become chronic and disabling [40]. The term 
musculoskeletal condition (MSC) refers to over 200 conditions which collectively place a major 
burden on the individual and society, and are known to cause pain and disrupt physical function [8, 
41]. MSCs are generally associated with pain and reduced function [8, 42, 43], however, these 
physical symptoms do not exist in isolation and have psychosocial consequences [44]; affecting 
mental well-being, ability to function in a social context and ultimately reducing quality of life (QoL) 
[8]. It is well established that MSCs are a major cause of disability globally [8, 41-43, 45, 46] and in a 
review by the World Health Organisation (WHO), it was noted that they are the main cause of 
disability in older age groups [8]. This same report predicted that the growing burden of MSCs would 
be felt more heavily in developing countries, and with MSCs being the fourth largest burden on 
health in developed countries and third largest in developing countries, this prediction would appear 




MSCs impose a great burden on both the individual and healthcare services [42, 48] and are one of 
the most expensive causes of disability [49]. The direct costs incurred as a result of MSCs are massive 
and include medications, physiotherapy, doctor’s appointments, hospital admissions and surgeries 
[41]. Of great importance and cost to both the individual and the economy is time spent off work as 
a result of MSCs. In 2007 more than 20% of incapacity claims in the United Kingdom (UK) were for 
MSCs and in another UK study from 2009, MSCs were second only to mental health problems in 
accounting for time off work [41]. The Global Burden of Disease 2016 study had similar findings in 
disability statistics with MSCs accounting for 17.1% of the total years lived with disability [50].   
At any point in time, 20-30% of adults in Europe are affected by some sort of musculoskeletal pain 
[42]. This is a similar finding to that of American populations where at any given time 30% of adults 
are affected by pain, swelling or limitation of movement in a joint [8]. According to a UK study, in 
2007, 14.3% of individuals reported having some sort of chronic MSC, whilst 12.1% of doctor’s visits 
were for complaints related to the musculoskeletal system [41]. A 2010 study conducted in two 
under-resourced Cape Town clinics found a 36% prevalence of MSCs [43]. Although these are not 
definitive prevalence estimates for entire countries, they provide some basis for comparison. 
Interestingly, there is quite a disparity between the 14.3% of reported chronic MSCs in the UK group 
and the 36% prevalence reported in the South African population. It has been suggested that 
poverty and low levels of education are positively associated with knee OA [51] and that lower socio-
economic status is positively associated with increased pain, and lower levels of function in adults 
with knee OA [52]. This may be due to a number of factors, but one may also speculate that this 
positive association may be related to the type of work which is more easily accessible to those of 
lower socio-economic position, namely manual labour. Given that OA is one of the most common 
MSCs affecting people globally [3-6], these findings, along with the higher burden of OA in 
developing countries [47], would suggest that the higher prevalence for the South African 
population estimates is in fact appropriate. Unfortunately, there is still a paucity of research looking 
specifically at the burden of MSCs in South Africa.  
There are a number of risk factors for the development of MSCs, such as inactivity and obesity (both 
of which are modifiable). However, the unavoidable and widely accepted common predisposing 
factor to the development of MSCs is advanced age [8, 42, 45, 49]. With the increased life 
expectancy which is now being seen around the world, the prevalence and burden of these 




Of all MSCs, OA is thought to be the most common [3, 5]. Considering this, it is interesting to note 
that that there are a number of ways in which OA may be defined. The general consensus amongst 
authors however, is that it is a condition associated with degenerative changes to the articular 
cartilage, which in turn leads to changes in the underlying bone [3, 7, 8, 40, 53-55]. Risk factors for 
the development of the condition include old age, female gender, obesity, previous joint injury, 
repetitive joint use, high bone density, muscle weakness and joint laxity [56].  
Prevalence statistics regarding OA are not available for all populations. Prevalence statistics vary 
greatly throughout the literature and are influenced by the way in which OA is defined [3], making it 
difficult to determine an exact prevalence of the condition.  However, where data are available, 
prevalence is reported to be high with 9.6% of males and 18.0% of females over the age of 60 
affected by OA worldwide [5, 7]. The prevalence of OA is known to increase with age [3, 5, 56]. It is 
also more common in females than in males as one would assume if being female is a risk factor for 
the development of OA [3, 56]. This male to female difference in prevalence is rather large with 
nearly double the percentage of females than males with OA Differences in prevalence between 
male and female populations in the United States of America (USA) were smaller, with 10% of males 
and 13% of females over the age of 60 estimated to have OA [56]. Prevalence estimates for OA in 
females were consistently higher than for those in males in studies conducted in China, Greece, the 
Netherlands, Spain and the USA [57]. Up to date statistics regarding prevalence of OA in South Africa 
are lacking, however, the general household survey conducted by Statistics South Africa in 2011 
reported that 13.9% of people over the age of 65 years reported having arthritis [58] and in a 1987 
report, chronic arthritis was ranked as the leading cause of disability in the metropolitan area of 
Cape Town [9]. With high prevalence rates globally, and the assumption that South Africa follows the 
same trend as the rest of the developing world, the financial burden of OA needs to be fully assessed 
to understand the magnitude of the problem the disease poses to those who are living with it. 
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A review looking at the costs of OA in the UK as compared to other countries suggested that 
accurate estimates or figures are similarly difficult to ascertain due to problems in defining OA and 
therefore in determining its prevalence. It was noted however, that OA is a growing financial burden 
on all countries, with costs varying from country to country [59]. As found with MSCs as a whole, the 
costs incurred as a result of OA include both direct (medication, physiotherapy, carers etc.) and 
indirect costs (time off work, reduced productivity and compensation for disability), of which indirect 
costs appear to be greatly underestimated [59]. A systematic review by Salmon et al (2015) found 
that the costs incurred due to OA differed depending on which continent was being assessed and 
found several limitations in the methods used by the studies they reviewed. Patient selection, as 
well as what constituted a direct cost were not the same throughout studies, which they noted 
would possibly bias or skew their results [60]. In North America, direct costs related to hip and knee 
OA were €10 000 per year, while in Europe these costs were only €1000 per year. They attributed 
the large difference to increased levels of obesity and comorbid conditions in the USA [60]. Taking 
the limitations of the review into account, the estimated total global cost of hip and knee OA was 
€11 100 per patient per year. Direct costs, estimated to be €9 500 per person per year globally, were 
greater than indirect costs overall, except for in Europe where they accounted for less expenditure 
than indirect costs. Indirect costs were estimated to be €4 400 per person per year globally [60].  
Unfortunately, costs relating to physiotherapy, alternative medicine, emergency room visits and 
surgery are not always included in these cost estimates, and this may lead to an underestimation of 
the direct costs [60]. There is a lack of evidence regarding the economic burden of OA in SA, 
however if it follows the global trend and the population continues to age, one would expect to see 
an increase in this cost burden over the next few years. This would severely stress an already 
overburdened healthcare system in South Africa. 
2.4 Symptoms of OA 
Pain is the most common symptom experienced by patients with symptomatic OA [54, 61]. 
However, OA is also known to contribute to reduced range of motion and disability [9-11]. As 
mentioned earlier, the effects of OA are not only physical; it can also have other devastating 
consequences for the individual affected by the condition. The personal, social and economic burden 
borne by the individual is significant, and beliefs regarding ill-health can lead to feelings of 
helplessness, reduced self-efficacy, reduced ability to cope, and depression [44]. This results 
ultimately in a reduced QoL for the individual living with OA along with increased expenditure on 
healthcare [11].  
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2.4.1 Pain mechanisms in OA 
Pain and disability show poor correlation with the severity of OA based on joint imaging. Imaging 
demonstrating OA is often not associated with any clinically important symptoms [62, 63]. A 2011 
report suggests that up to 40% of individuals with radiographic evidence of OA experience no pain 
[64]. This percentage was even higher according to a review published in 2001 where they suggested 
that as many as 50% of patients with radiographic knee OA do not experience knee pain, and 50% of 
those who complained of knee pain at the age at which OA is likely to become common, had no 
conclusive radiographic evidence of OA [65]. It is this nature of evidence which begins to suggest 
that there are numerous pain mechanisms at play in these patients.   
2.4.1.1 Central sensitisation 
Abnormal cartilage is one of the defining features of OA, however due to the fact that it is an aneural 
structure, it is unable to directly generate a nociceptive stimulus which could generate the pain 
associated with OA [63]. As a result, there have been a number of suggestions as to what peripheral 
structures and processes may be responsible for the generation and maintenance of pain in OA [22]. 
Both peripheral sensitisation (PS) and central sensitisation (CS) have been implicated in the pain 
experienced in people living with OA [22, 66, 67]. PS is thought to produce more localised symptoms, 
whereas CS creates a more widespread distribution of pain, distal to the actual injury or pathology 
[67]. The operational definition of CS  by Woolf, (2011, p. S5) is “an amplification of neural signalling 
within the central nervous system (CNS) that elicits pain hypersensitivity” [1]. According to 
Latremoliere and Woolf (2009), intense, sustained and repeated noxious input is required to induce 
CS [68]. The gate control theory postulates that pain requires the complex interaction of both 
ascending and descending pathways and central and peripheral systems in its generation and control 
by the brain [69]. This theory allows for a greater understanding of how the CNS may have a role in 
the pain experienced by patients with OA and that those in the sub-group who experience increased 
and persistent pain may have an imbalance or a dysfunction in these complex interactions which 
generate pain. Recent studies have investigated the role of the nervous system in OA pain, 
specifically the CNS. There is growing evidence to suggest that there may be a CS component to OA 
pain [1, 23, 63]. A systematic review looking at the role of central pain in OA found several studies 





When referring to CS, it must be considered that changes occur both in the spinal cord, as well as in 
the processing of inputs in the brain itself [22]. CS is mediated by a number of processes and 
ultimately results in a lowered threshold for nociceptive input at the spinal cord as well as the 
cerebral cortex, increased excitability at the spinal cord, increased receptor field size, windup and 
decreased function of descending inhibitory pathways [67]. These changes lead to the symptoms of 
hyperalgesia, secondary hyperalgesia and allodynia [68]. Hyperalgesia refers to increased pain from 
a usually painful stimulus [23]. Secondary hyperalgesia refers to increased sensitivity to pain in an 
altered distribution, i.e. distal to the site of injury or pathology [68, 70]. Allodynia is when pain is 
produced by a usually non-painful or sub-threshold stimulus [1]. These are all indicators of the 
presence of CS [68]. Taking these changes into account, it is clear that nociception is not necessary 
for pain to be present in patients with OA and that appropriate management should attempt to 
address this driver of pain.  
In the past, management strategies and treatments for OA have sought to address the disease at the 
site of the structural problem, but evidence is showing that this may not be enough for all patients 
as it fails to address the pathology in the CNS which contributes to pain [67]. If one were to assume 
that the joint pathology in OA is the primary source of pain, then the obvious assumption would be 
that total joint replacement would completely alleviate the patient’s symptoms, as the joint would 
no longer be damaged. This unfortunately is not the case, as evidenced by a systematic review 
assessing long-term pain in patients having undergone total hip arthroplasty (THA) or total knee 
arthroplasty (TKA). The results of the review suggested that in patients undergoing THA 4.8% - 20.5% 
experienced poor pain outcomes, and in the studies focussing on TKA, a conservative estimate of the 
percentage of patients who continued to experience long-term pain following surgery was between 
10% and 34% [24]. A European study considering primary arthroplasty, bilateral arthroplasty and 
revision arthroplasty, suggested that the percentage of patients with persistent pain following knee 
arthroplasty was slightly higher at 35% [25]. This same study found that the intensity of pre-
operative pain as well as a delay in the surgical intervention increased the patient’s risk of 
experiencing persistent pain following surgery [25]. Further, in a 2014 review from Lluch and 
colleagues, they noted that individuals with a higher pain rating and lower pain threshold pre-




The failure of a joint replacement to improve pain in these patients further strengthens the 
plausibility of the suggestion that another mechanism may be the primary driver of their symptoms, 
namely CS. One of the main drivers theorised to contribute to CS is fear avoidance beliefs. The role 
of fear avoidance in CS and OA will be discussed prior to a discussion on methods to assess CS. 
Thorough assessment is important to identify this sub-group of patients with OA of the knee who 
develop CS, in order to target them specifically to achieve the best possible outcome following 
surgery.   
2.4.1.2 Fear avoidance 
Fear and anxiety change an individual’s experience of pain, as well as their experience of disability as 
a result of chronic pain [72]. The fear-avoidance model was developed as a cognitive behavioural 
model for chronic low back pain to assist understanding in how disability develops as a consequence 
of chronic pain [73]. The model proposes that pain may be interpreted by the individual in different 
ways: either as threatening or non-threatening. This interpretation will lead to either an adaptive or 
a mal-adaptive response, which then has consequences on the individual’s ability to recover [73, 74]. 
A threatening interpretation of pain, e.g. that pain is a sign of damage, may lead the individual to 
reduce activity based on the understanding that avoidance is necessary to preserve their body. This 
reduced activity results in deconditioning so that when the individual does attempt activity, it is 
easier to generate nociception and pain, resulting in further avoidance and the initiation of a 
disabling cycle [73, 75]. Hurley describes fear-avoidance as dysfunctional behaviour where the 
patient will avoid activities which they believe to be harmful because of fear of pain and causing 
further harm [44]. It is important to remember that the behaviours exhibited by patients showing 
fear-avoidance are not inherently bad, and in the acute phase of an injury, can in fact be useful. It is 




















Figure 2: The Fear-Avoidance Cycle [72] 
 
Additionally, the avoidance of activities which may cause pain results in reward for the patient by 
reduction of fear, anxiety, pain etc., and thus further reinforces this pattern [72]. This cycle of fear 
avoidance not only creates physical disability and deconditioning, the resulting reduced participation 
can lead to depression, frustration, and irritability [72], which compound the problem further. Pain-
related fear also interferes with cognitive functioning, with a hyper-vigilant patient being unable to 
draw their attention away from pain related information and attend to basic daily tasks which 
require some problem solving [72].  Literature, not looking at fear-avoidance specifically, suggests 
that an individual’s current level of pain will influence their future function [20], essentially what the 





















In a study from the USA it was noted that higher fear-avoidance beliefs were associated with poorer 
function, however the study was unable to establish causality between the two [74]. A separate 
study in the Netherlands similarly did not establish causality, but noted that fear-avoidance was a 
sizeable problem and was negatively associated with function in patients with OA [76]. Furthermore, 
it is suggested that based on the results of the Dutch study, treatment strategies for those OA 
patients in the sub-group who experience high levels of pain-related fear be investigated in order to 
return them to their best possible level of function [76]. Using the fear-avoidance explanation, one 
may see that fear may drive CNS processes and contribute to the development of CS. 
2.5 Assessment of OA 
As mentioned previously, OA is defined in a number of ways, and as such, diagnosis may be made 
using a number of assessment methods. There are diagnostic recommendations available regarding 
the diagnosis of OA from both the American College of Rheumatology (ACR) [77] and the European 
League Against Rheumatism (EULAR) [78]. The Kellgren and Lawrence grading scale is a 
radiographical grading system used to classify osteoarthritis [79] A diagnosis may be made without 
radiographical imaging using both the EULAR and the ACR clinical guidelines, however the ACR 
guidelines have specific subset, which make use of imaging along with various other OA –related 
symptoms. In the current study, the patients had been diagnosed with OA and imaging had been 
conducted. None of these available guidelines take into account the potential presence of CS or fear-
avoidance beliefs and as such, they are not assessed as part of any diagnostic criteria. Of course, one 
may not necessarily have CS simply because OA is present, but as already established, there appears 





It may be useful to begin to look into assessing for CS and fear-avoidance as part of a diagnostic 
process in patients with OA, as it would allow for appropriate interventions to be commenced 
timeously. For a start, questioning regarding symptoms of CS maybe useful for screening those at 
risk. The Central Sensitivity Index (CSI) was developed with the goal of minimising or completely 
removing unnecessary diagnostic and treatment procedures by helping clinicians to better assess 
symptoms thought to be associated with CS and thus categorise syndromes more appropriately, 
identify sensitivity and severity, and plan treatment optimally [80]. NIjs et al (2014) have also 
created an algorithm for classifying pain as neuropathic, nociceptive or CS pain [81] This proposed 
algorithm makes use of the CSI and seeks to classify pain as CS, by excluding neuropathic and 
nociceptive pain [81]. Along with the CSI, the Tampa Scale of Kinesiophobia (TSK) could be used to 
assess fear of movement in these patients. The TSK will be discussed in greater detail in the section 




2.6 Current Management of Osteoarthritis 
2.6.1 Guidelines for management 
Due to the high prevalence of OA and the increased burden it places on the health system, as well as 
the individual, it is of utmost importance that correct management is implemented. Understanding 
that each patient is different in terms of their preferences and personality, health teams need to 
ensure that management strategies are tailored to be acceptable and appropriate in meeting the 
needs of the individual being treated [15, 17]. There are current guidelines available set out by 
various expert groups, which cover surgical and non-surgical methods; including pharmacological 
and non-pharmacological management of the condition. Guidelines have been produced by the ACR, 
EULAR, OARSI, NICE, and ESCEO.  
The 2012 update to the ACR guidelines focused on non-surgical guidelines for knee OA specifically, 
and include both pharmacological and non-pharmacological interventions [17]. The EULAR similarly 
offered guidelines for both the pharmacological and non-pharmacological management of OA knee 
[82]. The guidelines by the Osteoarthritis Research Society International (OARSI), the National 
Institute for Health and Clinical Excellence (NICE) and the European Society for Clinical and Economic 
Aspects for Osteoporosis and Osteoarthritis (ESCEO) include both surgical and non-surgical 
interventions, as well as pharmacological and non-pharmacological interventions for hip and knee 
OA [13, 83, 84]. The recommendations according to these guidelines for management of OA will be 
explored in further detail in the following sections, however the pharmacological interventions are 
not the main focus of this study and have been summarised briefly in Table 1. Notably, there has 
been an update to the OARSI non-surgical guidelines since 2008, but the surgical guidelines do not 




Table 1: Pharmacological interventions for OA knee 
OARSI [85] NICE [83] ACR [17] EULAR [82] ESCEO [84] 




NSAIDs or COX-2 
selective NSAIDs 
Oral NSAIDs (or 
COX-2 inhibitors 
with proton pump 
inhibitor) 
 
Oral NSAIDs (or 
non-selective 








agents or COX-2 
inhibitors) 
Oral NSAIDs (or 
non-selective 




Topical NSAIDS Topical NSAID Topical NSAIDs Topical NSAIDs Topical NSAIDs 

















Opioids  Opioids Opioids 
 

















 Tramadol   
Duloxetine    Duloxetine 
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According to the OARSI and EULAR recommendations, treatment of knee OA should be aimed at 
decreasing pain and stiffness in the affected joints, managing joint mobility, improving physical 
function, raising health-related quality of life, limiting further joint compromise, and teaching 
patients about OA and its management [13, 82]. There appears to be consensus throughout the 
guidelines that a combination approach using both pharmacological and non-pharmacological 
interventions allows for optimum management of patients with knee OA [84]. However, if these 
guidelines are viewed through the framework of the ICF, they are all lacking in terms of addressing 
participation in life roles. Perhaps there is an assumption that raising health-related quality of life 
would include this component of treatment. 
More importantly the focuses of this study, are the evidence based non-pharmacological 
interventions. Information or education, weight-loss when appropriate, and exercise are three core 
non-pharmacological interventions which feature in all the guidelines reviewed [17, 82-85]. In cases 
where the patient is not getting the desired relief of symptoms and functional gains from the 
combined conservative interventions, surgical intervention is recommended [13, 82-84]. A number 
of other non-pharmacological interventions suggested may be acceptable for use in the 
management of knee OA. These, along with the aforementioned non-pharmacological and non-




2.6.2 Non-surgical management 
2.6.2.1 Education 
Education is recommended specifically by four of the five guidelines reviewed [82-85]. The ACR 
guidelines do not specifically mention education, but recommend psychosocial interventions as well 
as the use of self-management programmes, which often rely heavily on education [17]. Education 
should focus on helping the patient to understand more about their condition, as well as the 
objectives of management [83, 84]. Though the more recent non-surgical OARSI guidelines 
recommend education, they do not specify as to what the topics should be [85]. The older OARSI 
guidelines suggest that along with the focus mentioned previously, education should include 
information regarding the importance of lifestyle changes (exercise, activity pacing, weight-loss) 
which may help to offload the affected joint [13] and the EULAR guidelines recommend that 
education addresses the nature, causes (specific to the individual), consequences and prognosis of 
OA [15].  The guidelines all seem to emphasise education about the pathology of OA and its 
management based on an understanding that pain is a consequence of joint damage. The guidelines 
do not appear to incorporate education about pain mechanisms and ensuring that patients 
understand that pain may be as a consequence of CS rather than of joint processes. This lack of 
detail about what educational topics should be provided makes it difficult to implement and 
evaluate. 
Education, in particular education which aims to increase patients’ self-efficacy, has been shown to 
reduce financial costs as it leads to fewer primary care consultations and is beneficial in decreasing 
pain and improving coping skills in patients with knee OA [82]. Interestingly, in formulating their 
guidelines, EULAR found that education did not appear to exert any effect on level of function [82]. 
As mentioned above, this might be related to the educational content or to the educational method 
not being aimed at increasing self-efficacy. The EULAR results also lead one to consider what other 
factors are at play which may influence the ability of the individual to translate knowledge into 
action or behaviour. Thus for optimal management of these patients, treatment needs to be multi-





Various types of exercise have been recommended for use in the management of knee OA. Exercises 
focussing on strengthening of the lower limb and muscles around the knee, joint mobility exercises 
and general aerobic exercises were recommended by several expert groups [82-85]. Exercise may 
also be land or water based [17, 82, 84, 85] and may serve as a helpful means of assisting with 
weight-loss for patients where this is necessary [86]. According to both the EULAR and ESCEO 
groups, consensus has not yet been reached on the optimum exercise programme or dosage for 
patients with knee OA [82, 84]. Thus, the intensity, dosage and type of exercise programme to be 
administered is left to the discretion of the physiotherapist or other healthcare provider 
administering the programme. 
Exercise may be done in group classes, in individual therapy sessions or at home without 
supervision. Each method of delivery has its own pros and cons, however all three provide effective 
relief from symptoms [86]. Having said this, the review by Bennell and Hinman (2011) also found 
that exercise supervision may be associated with improved results and that more than 12 supervised 
sessions showed better treatment effects than less than 12 supervised sessions [86]. In another 
review, evidence for the short-term benefits of exercise for patients with OA was overwhelmingly 
positive, however longer term follow up on these patients revealed that these benefits were not 
maintained over time [87]. Due to a lack of evidence, authors speculate that the reason for lack of 
long-term benefits in these patients may be a lack of adherence to exercise [87]. Once again, this 
emphasises the need for attention to the methods used in the delivery of both educational and 




2.6.2.3 Other modalities 
In addition to education and exercise, recommendations have been made for other modalities to 
assist in non-surgical management of these patients. These include both medical and alternative 
options. The more recent OARSI guidelines differ somewhat from all the other groups in that the 
only other options they recommend are balneotherapy1 (not mentioned in any of the other 
guidelines), cane use, and biomechanical intervention (including knee braces, knee sleeves, shoe 
wedges and insoles) [85]. Heat therapy, walking aids (when necessary) and transcutaneous electrical 
nerve stimulation (TENS) were recommended by three of the five guidelines [17, 83, 84]. There 
appeared to reasonable consensus supporting the use of manual therapy [17, 83, 84], bracing, joint 
support and insoles [17, 82-85]. Acupuncture was recommended in two of the guidelines as a 
technique for relief of symptoms [17, 84]. These are obviously not core recommendations as are 
exercise and education, but may be of assistance as additional symptom management for patients 
seeking greater relief.  
2.6.3 Surgical interventions 
Surgical options for the management of OA of the knee include total knee arthroplasty (TKA), 
unicompartmental replacement, high tibial osteotomy, joint lavage and arthroscopic debridement, 
or total fusion of the joint [13]. For OA limited to a single compartment of the knee, a 
unicompartmental replacement is recommended by OARSI as an effective treatment, and in young, 
active patients with severe symptoms from unicompartmental OA, a high tibial osteotomy may delay 
the need for TKA for several years [13]. Joint lavage and arthroscopic debridement may offer some 
short-term relief, however there is debate as to whether this is a result of a placebo response or as a 
result of the surgery itself [13] and according to the NICE guidelines it should not be offered 
routinely [83]. The possibility of a placebo response being effective may offer some support for the 
argument that a centrally sensitised system is driving pain in some these patients. In cases where 
TKA has failed, fusion of the joint may be considered as a final measure [13].   
                                                          
1 The use of baths containing thermal mineral waters (spa therapy) 
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Considering the focus of the current study, TKA will be the main discussion point. TKA is a procedure 
which should only be considered when the patient is no longer receiving the desired relief and 
functional improvement from conservative and pharmacological management, or when physical 
function has deteriorated to a point where it is no longer adequate [13, 16]. According to OARSI 
guidelines, TKA is the most appropriate treatment for patients who no longer respond to non-
surgical management [13]. When assessing the success of a TKA in terms of radiographical 
appearance of the artificial joint, prosthesis survival and outcomes as evaluated by the surgeon, it 
appears to be a highly successful intervention [24] and this appears to be true for most patients. The 
problem however, as mentioned earlier, is that there are a noticeable percentage of patients who do 
not obtain the desired and expected pain relief and improvement in function following surgery [24]. 
A group of 10% - 34% of patients undergoing TKA and not achieving good outcomes is alarming and 
requires the attention of clinicians and researchers alike to design and implement management 
programmes which focus on more than just the physiological impairment but that address the CS 
aspects for these individuals. One method to address these aspects is education and exercise 
focussing on reducing the fear of movement. 
2.6.3.1 Barriers to surgery 
Even though TKA is recommended, there are barriers to this management option. In the South 
African context, the main barrier is accessibility. Waiting lists are a common problem and the 
evidence regarding the effects of being placed on a waiting list for joint replacement yield mixed 
results. Several studies suggest that being placed on a waiting list has a negative effect on an 
individual which may include reduced levels of activity, reduced quality of life (QoL) and increasing 
impairment of function [19, 88-92]. Interestingly, a study by Ackerman in Australia found that 
amongst individuals placed on a waiting list for joint replacement surgery, those with the lowest 
income had the worst HRQoL, and that those with the lowest income or the lowest level of 
education experienced the most psychological distress [92]. These findings are particularly relevant 
in a South African State health setting where the majority of patients are from low-income 
households with low levels of education and waiting times for surgery often exceed two years[18]. 
However, the Australian study did not assess HRQoL of individuals prior to being placed on the 
waiting list, thus making it difficult to assess causality. With these long waiting lists and poor access 
to surgery, patients require alternative management strategies. Self-management groups may 
provide a promising alternative. 
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2.6.4 Self-management groups 
Self-management refers to the active participation of a patient in their own health and their ability 
to manage it on a daily basis [93, 94]. Clark et al (1991) describes self-management as being based 
on Bandura’s social cognitive theory which suggests that human behaviour is governed by the 
interaction of personal, environmental and cognitive factors [93]. Using this theory as a base from 
which to work, self-management programmes strive to change the perception of the individual 
regarding their ability to manage themselves and their health. Perceptions are changed using 
education about their condition and encouraging discussion around relevant points related to this, 
goal setting, and monitoring of changes in behaviour [93-95]. For patients with chronic conditions, 
effective self-management is not simply a once off treatment, but requires life-long commitment to 
managing themselves and their illness well [94] and unfortunately problems relating to adherence 
are not uncommon [96]. 
Self-efficacy, as described by Bandura (1977), relates to an individual’s confidence in their own 
ability to execute a behaviour in order to achieve an outcome [97]. It is this confidence which is 
referred to in the previous paragraph regarding the individual’s perception of their ability to self-
manage. As mentioned earlier, beliefs regarding ill-health can lead to feelings of helplessness, 
reduced self-efficacy, reduced ability to cope, and depression [44]. Along with this, misconceptions 
around pain, activity and damage, leading to a drop in physical activity to spare the joint, can 
increase disability in patients with knee OA [75]. As discussed previously, self-management 
interventions aim to increase self-efficacy [95]. Self-management interventions challenge incorrect 
beliefs and are important in the provision of alternative, more accurate information on which to 
base new beliefs , and thus provide facilitation towards more appropriate physical behaviour [75].  
Studies evaluating the effectiveness of self-management programmes for people living with OA have 
yielded mixed results. Two separate systematic reviews have assessed a number of self-
management group intervention studies [98, 99]. Notably none of the included studies in the 
systematic reviews included an exercise component. A small effect size of 0.1 was found [98] and 
both of the reviews suggested that individuals with OA seem to benefit minimally from self-




The 25-year old Arthritis Self-Management Programme (ASMP) is an arthritis specific self-
management programme which was developed out of a needs assessment conducted on arthritic 
patients and their rheumatologists [100] and is based on self-efficacy theory [95]. The programme 
consists of six two-hour sessions, held once a week and led by two trained peer-educators, at least 
one of whom has a rheumatic condition. Group sessions are not conducted in hospitals or clinics and 
usually happen at community centres or other community venues. Any patients with rheumatic 
conditions may enrol, and their partners may also attend. The group sizes are limited to between 10 
and 15 participants [100]. Participants receive the Arthritis Helpbook as a reference guide and goal-
setting and report-back are important aspects of the course [95]. The programme includes education 
regarding exercise, but does not include an exercise component during a session [98, 100]. 
The Chronic Disease Self-Management Programme (CDSMP) is based on the same principles as the 
ASMP but is a more generic programme which can be applied to a variety of chronic conditions 
[100]. Participants receive a reference book on Living a Healthy Life with Chronic Conditions [100]. It 
also runs for six-weeks, however sessions are two and a half hours long and not two hours like the 
ASMP. It is peer led and community based like the ASMP [100]. It also provides education regarding 
exercise, but does not include an exercise component in the session [98]. Anyone with a chronic 
disease is eligible for participation in this programme, resulting in greater heterogeneity in these 
groups than those of the ASMP [100]. 
In a study comparing the ASMP and the CDSMP for use by patients with arthritis in the USA, it was 
found that both were beneficial, however at four months and one year follow-up the ASMP group 
showed greater improvement in health distress, fatigue and activity limitation than those with 
arthritis in the CDSMP group [100]. Participants were not excluded if they had arthritis which was 
not OA and as such this study included those with rheumatoid arthritis (RA) and ‘other arthritis’. 
Though the focus of the study was to compare the two interventions, it may have been useful to 
include a control group for further comparison. The results of this study appear promising for 
arthritis-specific programmes, however they are difficult to generalise to a South African population 




Another randomised controlled trial (RCT) assessing the ASMP in a UK population found that 
improvements in perceptions of control, use of health-management techniques (including exercise) 
and health status were all maintained at four and 12 months follow-up in the ASMP group compared 
to the control group which was placed on a four-month waiting list. Along with these improvements, 
patients  in the ASMP group needed to visit their general practitioner less often at the 12 month 
mark than those in the control group [95]. The majority of the sample in this study was female, and 
in both the control and the experimental group, only 52% of the participants had OA. The remaining 
48% included RA and other [95]. Notably, 52% of the participants in each group also had some sort 
of formal educational qualification, suggesting that there was generally a fairly high level of 
education in the sample [95]. Interestingly, although an improvement in the use of exercise was 
noted and maintained at 12 month follow-up, physical function levels remained relatively 
unchanged in both groups throughout the course of the study, and a small reduction in physical 
function was even noted in those with OA at 12 month follow-up [95].  
The results seem to contradict one another as one might assume that if exercise increased, so 
should physical function. It is possible that the method of data collection, posted questionnaires, 
was not an accurate way to evaluate function. It would be more accurate to measure function 
through physical tests. Once again, this study is not entirely generalizable to the population in in the 
current study as education levels are vastly different. Increasing exercise participation in the 
intervention group is finding, despite the findings regarding levels of function. These results 




As previously noted, the ASMP does not contain an exercise component, however it does educate 
patients about exercise [95], which may have a part to play in the success of the programme. The 
education section of a successful self-management programme aims to teach new skills which 
facilitate behavioural changes and create a sense of self-efficacy with which the patient can then 
continue to make good decisions regarding their own health [93, 94]. However, the lack of an active 
exercise component in the ASMP may limit the effectiveness of the intervention. This separation of 
education from active participation in exercise within self-management groups was noted by Hurley 
and Walsh [75]. Based on current evidence suggesting that an exercise component may be a crucial 
aspect in the creation of a successful self-management programme, this separation poses a problem 
[11]. This is an interesting omission given that the ASMP is based on self-efficacy theory, as the 
theory itself suggests that the patient needs the opportunity for personal mastery of a task for the 
fostering of self-efficacy [97]. Thus, whilst the ASMP and CDSMP yield positive results by providing 
only education and monitoring of behaviours, there is a gap in providing patients with a regular, 
structured opportunity to practice exercise in a safe and controlled environment with a trained 
group leader or health professional.  
Though not explicitly stated, the ESCAPE knee pain programme appears to have been developed 
around the principles of a biopsychosocial framework and is based on the ICF understanding that 
physiological, psychological, behavioural and socio-economic variables all contribute to the physical 
function, pain, behaviour, and health-care use of an individual [11]. The programme makes use of 
education and group discussion, graded exercise, and self-management strategies and aims to 
change the unhelpful beliefs and behaviours of the participants regarding their condition and their 
ability to be physically active [101]. The programme may be delivered as an individual intervention 
or as group rehabilitation, with both modes of delivery yielding improvements in function for up to 
six months following the intervention [102]. Groups consist of eight participants and are held twice a 
week for six weeks [102]. The education and discussion section of the sessions typically runs for 15-
20 minutes and is followed by 35-45 minutes of an individualised exercise programme for each 




The ESCAPE-knee programme was found to be more clinically- and cost-effective in a UK cohort than 
usual care in the short term, and provided benefits which were still evident at 30 months follow-up 
[11]. As with the previous studies, the sample consisted mainly of females, however education levels 
were not reported on, leaving a gap in the reader’s ability to compare with other literature [11]. 
Participants were also accepted with a history of more than six months of mild to moderate knee 
pain and a clinical diagnosis of OA from their doctor, without any imaging to confirm this diagnosis 
[102]. Follow-up was also only done immediately following the intervention and then 12 months 
later [101], making it difficult to compare the results of the ESCAPE trial to those of the current 
study. Interestingly, the ESCAPE study, did not manage to recruit their target number of participants 
leading one to wonder if this a common problem with studies of this nature in this specific patient 
population. 
A recent study conducted in a Cape Town population awaiting hip and knee arthroplasty [29], made 
use of a “Living with OA” programme which was based on the ASMP [100], the ESCAPE knee pain 
programme [102], and the Positive Living Self-Management Programme [103]. The programme 
includes six sessions held once a week over six weeks in succession. Each class or session runs for 
two hours and includes an education component, an exercise component and relaxation training 
(Appendix A). The programme is designed to be facilitated by a physiotherapist who is trained in 
providing the information and exercise. Groups consist of a maximum of 12 individuals, allowing for 
the development and fostering of relationships between participants and meaningful discussion, 
whilst still ensuring that the facilitator maintains coherence [103]. Goal setting on a weekly basis is 
used to facilitate increases in self-efficacy and behaviour change. 
The study by Saw (2015) examined the effects of a six-week physiotherapist-led exercise and 
education based intervention on patients awaiting total hip and total knee arthroplasty in a Western 
Cape population. There were positive results in the experimental group when compared to the 
control group that showed significant improvements in pain severity, pain interference and function. 
These encouraging results were all maintained at six months follow-up [29]. The sample group in this 
previous study may be useful for comparison in that it was very similar, with the only real difference 
being that people with hip OA were included [29]. The most notable difference between the 
populations in the previous and current studies is that participants in the previous study were still on 




It has already been mentioned that 10%-34% of patients undergoing TKA continue to experience 
persistent pain following their surgery [24], and it has also been suggested that a possible cause may 
be the development of CS in these patients [1, 23, 63]. In the state health setting in South Africa 
waiting lists are known to be lengthy, and as already discussed severe pain and a longer waiting time 
for surgery put patients at an increased risk of persistent pain following TKA [25]. The evidence 
above suggests that intervention groups can provide improvements for those on a waiting list, 
especially if they include an exercise component. These interventions improve pain because they 
appear to address both peripheral and central pain mechanisms, thus addressing CS in these 
patients [104]. Perhaps if one could improve pain and function pre-operatively, post-operative 
outcomes could be improved.  
Optimising health status before surgery should be an important feature of pre-operative 
management [105], and patients on a waiting list for TKA are prime candidates for participation in 
interventions aiming to minimise pain and maximise function with the objective of optimising 
surgical outcomes. None of the studies reviewed above have conducted any post-surgical follow-up 
or have provided the intervention before surgery in the hopes of improving surgical outcomes in 
these patients. So far, patient self-management interventions have been used in isolation as a 
means of improving quality of life, pain and function in individuals with knee OA for whom surgery is 
not imminent. At present there appear to be gaps in the literature relating to the effects of these 
interventions on post-operative outcomes and the current study aims to take a step in the direction 
of assessing whether or not the promising results in the available literature may be the same for 
patients undergoing surgery. To effectively determine whether post-operative outcomes are 




2.7 Outcome measures 
There are six primary outcome areas which need to be considered when conducting clinical trials on 
patients with chronic pain as set out by the Initiative on Methods, Measurement, and Pain 
Assessment in Clinical Trials (IMMPACT) [106, 107]. These six areas include 1) pain, 2) physical 
functioning, 3) emotional functioning, 4) participant ratings of improvement and satisfaction with 
treatment, 5) symptoms and adverse events, and 6) participant disposition [108]. Bearing this in 
mind, consideration was made of various outcome measures in an attempt to most accurately 
evaluate the above listed areas.   
2.7.1 Pain  
Since pain is the most noticeable symptom in most people with arthritis, and is the most important 
factor in determining disability in patients with OA, it is the primary outcome measure in this study 
[8]. Using the IASP definition of pain, it is accepted that pain is experienced both physically and 
emotionally at the same time, and that it is a completely subjective experience[26]. This makes 
measuring pain a difficult task, however a number of tools have been designed to perform this 
function. 
The numerical rating scale (NRS), Visual Analog Scale (VAS) and Verbal Rating Sale (VRS) are all 
unidimensional tools, measuring pain severity. The NRS is usually scored along a line with the left 
end being zero (no pain) and depending on the highest number used, the right end is either 10 or 
100 (worst pain). The VAS is similar in that the patient is provided with a 10cm line, along which they 
can mark their pain (lowest to highest). The VRS is more appropriate for patients who may struggle 
to express their pain using a numerical value, and uses the descriptors of “no pain, mild pain, 
moderate pain and severe pain”[109]. These tools are useful in that they may be quickly 
administered and are generally easily understood by patients making them useful clinical bedside 
tools. However, due to their simple nature they do not assess the other complex aspects of the pain 
experience [110] such as pain interference with function, impact on QoL, and participation in 




The McGill Pain Questionnaire (MPQ) is a 78-item, multi-dimensional tool used for assessing the 
sensory and affective aspects of pain [110]. It is administered by an interviewer, and meanings of 
words are clarified as necessary. It may take up to 20 minutes to complete [110]. The Short-Form 
McGill Pain Questionnaire (SF-MPQ) was developed by the original designer in response to the 
realisation that the full MPQ was too long and complicated to be used in most clinical research 
[111]. Both the MPQ and the SF-MPQ are valid and reliable tools for measuring pain and have been 
used widely [110], however their use of fairly complex language and the length of time to complete 
the MPQ make them inappropriate for use in the current research setting. From the available 
literature, it does not appear that the MPQ or the SF-MPQ have been translated or validated for use 
with an isiXhosa population in South Africa. 
The measure of Intermittent and Constant Osteoarthritis Pain (ICOAP) is another multidimensional 
tool, developed by Osteoarthritis Research International (OARSI). It was designed to measure the 
pain experience of people with knee and hip OA specifically. There are separate versions available 
for the hip and knee [110]. It is easy to understand, and has been translated from English into 
several other languages. Unfortunately, although translation has been done widely, studies 
evaluating the validity, responsiveness and reliability of the tool have not been conducted for all 
those translations [110] and translation has not yet been done into either Afrikaans or isiXhosa. 
The BPI is a short, self-administered questionnaire assessing pain severity, and pain interference 
with function [106, 112]. Originally designed for measuring pain in cancer patients, it has since been 
validated for use in chronic, non-malignant pain, non-cancer pain and OA [34, 35]. Reliability scores 
for both pain severity and pain interference scales range between 0.82 and 0.95 [34]. Having been 
widely used in research and translated and linguistically validated in both Afrikaans and isiXhosa 
[113, 114], the BPI short form provides a useful tool to be used in measuring pain severity and pain 
interference in a Western Cape population. The BPI was also used successfully in two recent studies 
conducted in a South African population with OA, awaiting total hip or total knee replacement [29, 
115]. Furthermore, one recent study in particular [29] made use of the BPI in the same population 
group and setting in which the current study is to be carried out, suggesting that it is indeed an 




2.7.2 Physical Functioning  
As prescribed by the IMMPACT group, physical functioning is one of the primary areas needing to be 
assessed in any clinical trial involving patients with chronic pain [108]. There are a number of tools 
available to assess physical function and disability, however not all are appropriate for use in 
patients with OA. The Health Assessment Questionnaire (HAQ) is a 20-question self-report tool in 
which the higher an individual’s score, the greater the level of disability [116]. It has been validated 
numerous times, translated into over 60 languages and culturally adjusted as appropriate, and has 
been used in populations with OA [117]. Interestingly however, in a recent study conducted in a 
Cape Town population where the HAQ was used to assess disability, the author suggested that for 
future studies the WOMAC (which is OA specific) be considered instead. This suggestion was made 
to cross-validate the pain interference score on the BPI [29].  
The Knee Injury and Osteoarthritis Outcome Score (KOOS) was developed for use in younger 
populations with knee injury or OA [118]. According to a systematic review by Collins et al (2016), 
the KOOS was sufficiently valid, reliable and responsive for use in patients with OA of the knee [119]. 
The reliability, validity and responsiveness of the KOOS for older populations has been studied and it 
has been established as a suitable tool for use in older patients in Sweden [118] and in the USA 
[120]. However, the tool has not yet been translated and validated in either Afrikaans or isiXhosa 
and studies could not be found having used the tool in South African populations. 
The WOMAC, having been used widely in research assessing patients with hip or knee OA [11, 101, 
102, 121, 122], has proven to be a useful arthritis specific tool when it comes to evaluating disability 
and level of function. In a UK study comparing the HAQ, the Short Form-36 and the Euroqol, the 
WOMAC was established as the assessment tool of choice when it came to evaluating the outcome 
of TKA [123]. It evaluates pain, stiffness and physical function and there are both Likert and Visual 
Analog Scale (VAS) versions available [36]. It is a valid and reliable tool for use in patients with OA, 
and has been translated for use into one of the two languages needed for this study; Afrikaans [124]. 
In a Swedish population awaiting TKA, the internal consistency scores of the pain, stiffness and 
function sub-scales of the WOMAC were 0.91, 0.91, and 0.98 respectively [125]. The WOMAC at this 
point, has not been translated and validated in isiXhosa and therefore for the purposes of the 
current study it will need to be translated into isiXhosa and its reliability and, if possible, validity 




2.7.3 Health-related QoL 
Health-related quality of life appears to be somewhat difficult to pin down and explain in one 
definition. There are at least four definitions used throughout the literature according to Karimi and 
Brazier (2016 p. 646), with the two which appear most appropriate being, “How well a person 
functions in their life and his or her perceived wellbeing in physical, mental, and social domains of 
health” and “those aspects of self-perceived well-being that are related to or affected by the 
presence of disease or treatment” [126]. As suggested in the previous paragraphs, OA may have 
devastating effects on the individual which are not only physical in nature [44] and in order to treat 
the patient holistically and appropriately these emotional/ psychosocial aspects should not be 
neglected.  
A number of tools are available for assessing health-related quality of life (HRQoL). The Sickness 
Impact Profile (SIP) is a broad HRQoL measure designed to be applied to a number of different 
health conditions, measuring perceived health status [127]. The tool was developed over six years 
and contains 136 items in the questionnaire [127]. It has been found to be sufficiently valid and 
reliable for use in a variety of conditions [127], however given the length of this tool and the 
expected low levels of education in the current sample, it is likely to be inappropriate for measuring 
HRQoL.  
The Medical Outcomes Study 36-Item Short-form Health Survey (SF-36) was designed for use in both 
research and clinical practice [128]. According to Stewart (2007), it is the most widely used generic 
health survey [129]. As the name suggests there are 36 items which the patient must respond to in a 
self-administered questionnaire [129]. The tool has shown adequate validity and reliability for a 
number of populations and health conditions, including OA [129, 130] and has been standardised 
[128]. According to campaign.optum.com the tool has also been translated into Afrikaans and 
isiXhosa [131], both languages spoken by participants in the current study. The source did not 
provide information regarding the validation in these languages. Although the name suggests brevity 
of the tool, it is in fact quite a long questionnaire and given the number of tools being used and the 
lower levels of education in the population being studied, the researcher aimed to use the simplest 




The abbreviated version of the SF-36, the Short Form 12 (SF-12) is also a general health status 
questionnaire and was originally developed in the USA [132]. It was developed and tested on a 
European cohort across nine different countries and found to have a strong correlation with the 
results on the SF-36, leading the authors to suggest that it is a suitable, more practical alternative to 
conducting the full SF-36 in those countries [132]. As is the case with the longer version, the SF-12 
has been translated into both Afrikaans and isiXhosa, but information regarding the validation in 
these languages could not be found [131]. 
The EQ-5D-5L is one of the most commonly used tools for measuring HRQoL [133]. The three-
question version (3L) has been validated and its reliability established for use in South Africa, but the 
five-question version (5L) has not yet been tested [133]. The 5L has been translated into both 
isiXhosa and Afrikaans, with strict checks and cognitive debriefing having been done to ensure 
cultural equivalence and face validity of the translations (personal communication Jelsma, 2015). 
Both of the translated versions are recognised by the EuroQol Group [133, 134].  
Both the SF-12 and the EuroQol Instrument (EQ-5D) have been used in research, however no norms 
exist for either of these tools in a South African population[135]. The closest normative data is for 
Zimbabwe, another African country, and this is only available for the EQ-5D. When comparing the 
SF-12 with the EQ-5D-5L, the latter seemed the more appropriate option, given the simplicity and 
brevity of the tool and that two recent studies in a South African population made use of the EQ-5D 
5L successfully, one of which was conducted in a population similar to the one to be studied [29, 
115]. Despite the 5L having not yet been tested on this population, it will be used in the current 
study as it is expected that it will be more sensitive to change over time than the 3L as it provides 





OARSI has recommended that functional performance tests include the 30 second chair-stand test, 
40m fast-paced walk test, a stair climb test, a timed up and go test (TUG) and six minute walk test 
6MWT [136]. Selection of these tests was carefully considered based on three specific activity 
themes which are pertinent to patients with OA and which interventions often aim to improve. 
These were 1) walking tests, 2) stair negotiation tests and 3) sit-to stand tests. Within each theme 
there were several tests available to assess it and as such aspects of feasibility, measurement 
evidence and scoring played a role in selection [136]. Importantly, they recommend that these tests 
are used along with patient report measures as complementary assessments [136].  
One measure of function, the Stratford Battery uses four of these tests to assess pain and physical 
performance in patients with OA. These include a self-paced walking test, a TUG test, a stair test and 
a 6MWT [137]. All of these appear to be appropriate for assessing lower limb function in patients 
with knee OA. In the study by Stratford et al (2006), which was unfortunately limited by a small 
sample size, they suggested that the stair component of the battery be excluded from a composite 
score analysis as it leads to a less distinct impression of pain and function [137]. They do stress that 
although it should be excluded from the composite score in order to get the most accurate 
impression of the patient’s pain and function, it should not be left out altogether [137]. This is 
problematic from a research perspective as it suggests that the Stratford Battery in its entirety is not 
a suitable tool for assessment of function in clinical trials and according to OARSI’s 
recommendations a stair climb test is one of the core tests that need to be conducted [136] 
A large systematic review by Freiberger et al (2012), evaluated the Continuous Scale Physical 
Performance, MacArthur battery, Modified Timed Movement Battery, Mobility-Related Limitation 
Index, Physical Capacity Evaluation, Performance-Oriented Mobility Assessment, Performance Based 
Physical Function Test, Physical Performance Test, Shinkai Summary Performance Score, Short 
Physical Performance Battery, Task Modification Scale and the Upper Extremity Summary 
Performance Score [138]. They recommended that the Short Physical Performance Battery (SPPB) be 
used as it performed best on measures of reliability, validity and responsiveness. The two next best 
alternatives, according to the authors, were the Physical Performance Test and the Continuous Scale 




The SPPB is made up of balance tasks; side-by-side stand, semi-tandem stand and full tandem stand; 
an eight meter timed walk test; and a timed five times sit-to-stand-test [139]. As already mentioned 
it has demonstrated good reliability, validity and responsiveness [138] and has been used in studies 
on the elderly [139]. The test takes approximately 10-15 minutes to complete [139] which, when one 
considers that there will be four other questionnaires used in the current study, is quite time 
consuming. It also has a specific balance component to it, which may not be appropriate for this 
population. Another problem with the SPPB is that it does not have a stair climb component to it, 
which, based on the OARSI recommendations, makes it less suitable for the research to be 
conducted.  
The CS-PFP is a long test, made up of 16 household tasks, which the patient performs in a way that 
they prefer. It takes up to an hour to complete and requires the use of a laboratory space [140]. The 
tool is valid and reliable for use in a variety of patients [140]. A shorter version, consisting of ten 
items, has been developed as an alternative [140]. Both are valid and reliable and satisfy the OARSI 
recommendations for tests of function [140]. The length of both of these versions, as well as the 
inclusion of aspects unrelated to lower limb function make them inappropriate for use in the current 
study. 
Formerly called the Aggregated Function Performance Time, the ALF has been used successfully in 
research on patients with OA (Personal communication Hurley, 2015). The tool is valid and reliable 
for use in patients with OA [38]. Although not validated for use in a South African context 
specifically, the tasks to be performed are generic and can be applied to any context. The test 
consists of four timed tasks, namely: a straight line walk, an up and go test, stairs ascent and stairs 
descent. The total time taken for the four tasks is calculated, and then divided by four, providing the 
researcher with the mean time for the test. The four tasks in this test, whilst not the exact tests that 
OARSI recommended, satisfy the themes to be addressed in that there is a walking test, a stair climb 
test and a sit-to-stand test [136]. The ALF is simple and easy to administer, has been used in OA 
studies as previously mentioned, and the generic nature of the tasks allows for easy application in 




2.7.5 Fear of movement  
There are a number of tools which have been developed for measuring pain related fear and the 
constructs thereof [141]. In a review by Lundeberg et al (2011) they state that consensus regarding 
assessment and thus interpretation of fear related pain has not been reached [141]. According to 
their review, the current conceptual framework surrounding pain and fear is unclear, however they 
have made suggestions as to what may appear to measure each construct best. The three most 
commonly used tools are the Fear Avoidance Beliefs Questionnaire (FABQ), the Pain Anxiety 
Symptoms Scale (PASS) and the Tampa Scale of Kinesiophobia (TSK) [142]. 
The FABQ was originally developed for use in patients with low back pain. The original version was 
made up of 16 questions, divided into two categories, relating to work and physical activity [141, 
142]. It has been used widely and in the review, the authors suggest that it is most appropriate for 
measuring fear-avoidance beliefs [141]. Given the poor description of the underlying conceptual 
model of fear-avoidance beliefs, they suggest that results be interpreted with caution [141]. Gatchel 
et al (2016) suggest that the specific reference to “work” in the FABQ may limit its use to those who 
are working or who have been kept out of work by pain [142]. The majority of the population in the 
present study are unemployed or retired, making a questionnaire with strong links to work less 
appropriate for this group.   
The PASS was developed to measure pain-related anxiety and fear [143]. The PASS has been found 
to be a clinically useful tool, with its psychometric properties well established [143]. According to 
Lundberg et al (2011) it appears to be the best tool for measuring pain-related fear, even though 
there were issues around the description of the conceptual model of pain related anxiety and fear 
[141]. Patients provide a response to questions relating to cognitive, physiological or motor aspects 
[141]. Initially designed as a lengthy 40-item questionnaire, it has since been modified to have a 
short form for increased ease of use. By reducing each of the four subscales to contain five items 
instead of ten, they managed create a 20-item questionnaire measuring pain related anxiety and 
fear [143].The development of this 20-item scale suggested that it maintained the validity and 
reliability of the longer form version and may be a useful alternative in practice [143]. The current 
study sought to assess fear-of movement in OA and as such a tool measuring anxiety as a focus was 
deemed inappropriate. Even though the questionnaire has been abbreviated to 20 questions, there 




The TSK was developed originally for use in patients with chronic back pain, but since its translation 
for use in a Dutch population, extensive work has been done to ensure it is valid for use in patients 
with acute back pain, osteoarthritis and fibromyalgia [39]. The full TSK has been shown to have good 
validity and reliability in populations with chronic lower back pain, acute lower back pain, neck pain, 
fibromyalgia and shoulder pain [144]. The original TSK consists of 17 items, however it is available in 
17, 13, 11 and 4-item versions. According to Lundberg et al (2011) it is the most appropriate tool for 
measuring kinesiophobia which is described as excessive, irrational fear of movement or activity 
because of a feeling of vulnerability to injury [141]. There do not appear to be any other appropriate 
measurement tools for measuring fear of movement as a construct and so although kinesiophobia 
refers to irrational and phobic feeling, the TSK appears to be a promising option for measuring fear 
of movement in this population. It is also helpful for use in this population that it is not grounded in 
work-based references and is valid for use in patients with OA specifically [39].  
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Chapter 3: Methods 
3.1 Research Design 
A single-blind, randomised controlled trial was conducted to determine the effects of a six-week pre-
operative physiotherapist-led exercise and education intervention on post-operative recovery in 
patients with OA undergoing total knee replacement. In a study such as this where the patients are 
active participants in treatment it was not possible to blind patients, thus the research assistant 
conducting the data collection was blinded to minimise bias in the data collection process.  
3.2 Sample 
The participants for this study were taken from the population of those diagnosed with knee OA in 
South Africa, more specifically those diagnosed with knee OA and receiving public healthcare. The 
sampling frame used was those placed on a waiting list for a TKA at TBH in the Western Cape. The 
principal investigator was granted access to this waiting list and participants were randomly selected 
by random number allocation from this list for potential inclusion in the study. To be considered a 
potential participant, patients were required to be between the ages of 50 and 70 years of age, to 
have been on the waiting list for at least three months and be deemed suitable to undergo TKA 
surgery in the next three months. The specific age range of 50-70yrs old was selected based on the 
study by Saw (2015), as the current study aimed to investigate the same population group, including 
only TKA patients. Thus, the age requirement was maintained in line with that of the previous 
research. Those meeting these inclusion criteria were contacted telephonically and if on screening 
were found to be appropriate to participate in the study, were randomly selected by the principal 
investigator for inclusion.  
Patients who had participated in a similar education and exercise programme (used in a study by 
Saw et al. (2015) which preceded the current study) were excluded; however, patients in the care of 
a physiotherapist were not excluded. Receiving routine physiotherapy treatment was recorded but 
was not used as an exclusion criterion as the treatment was unlikely to be similar to the intervention 
used in the current study. Use of an assistive device was not a reason for exclusion as it was 
expected that a large portion of these patients would be using some sort of device for easier 
mobilisation. Use of assistive devices was simply documented. 
The total initial pool for sampling consisted of 455 individuals. Following a screening of those on the 
waiting list, 313 potential participants remained. As a result of this large pool, random selection was 
done to begin telephonic recruitment. Full inclusion and exclusion criteria are included in Table 2. 
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Table 2: Inclusion and Exclusion criteria for participation in the study 
Inclusion Criteria Exclusion Criteria 
1. Willing to participate and able to commit to 
attending the intervention should they be 
allocated to the intervention group. 
2. Between the ages of 50 and 70 years old. 
3. Diagnosed with knee OA. 
4. On the TKA waiting list for more than three 
months. 
5. Deemed suitable, by the surgical team, for 
surgery within the next three months. 
6. Scheduled to undergo TKA within the next 
three months. 
7. Able to both read and understand either 
English, Afrikaans or isiXhosa to a Grade 8 level. 
1. Previous knee surgery or trauma. 
2. Presence of both hip and knee OA. 
3. Previous participation in a six-week self-
management programme aimed at reducing 
pain and increasing function. 
4. Any diagnosed cognitive impairments. 
5. The presence of any other inflammatory 
condition which may be contributing to their 
pain or any other leg or back condition which 
may be contributing to their symptoms. 
6. Patient deemed unsuitable for exercise 
according to the American College of Sports 
Medicine Guidelines (ACSM) screening 
(Appendix J) and subsequent inability to 
complete a 6 minute walk test (6MWT). 
 
Despite several attempts to contact those appropriate to participate in the study, many of the 
potential participants were unreachable (n=158). Of those with whom telephonic contact was made, 
a large percentage were unsuitable for further involvement, either simply declining (n=34) or 
meeting one or more of the exclusion criteria (n=62). Participants who indicated a willingness to 
participate on the phone, proceeded to meet with the principal researcher as well as a research 
assistant, to further assess suitability for inclusion in the study. On meeting with those interested in 
participating, a further 20 participants were excluded. Those suitable for inclusion after this process 








3.3 Sample size and power analysis 
Sample size was calculated using the primary outcome measure of change in pain severity of three 
points out of a possible ten (a clinically significant change in pain) with a standard deviation (SD) of 
2.29 based on the data from the previous study performed at TBH by Saw et al. (2015). Based on six 
data collection points and using an alpha level of 0.05 and power of 0.9, a minimum of 28 
participants was required, with 14 participants in the experimental and control groups respectively. 
The recommendation for group based treatments is that they utilise a maximum of 12 people per 
group [103]. To allow for attrition and to optimise group effectiveness it was decided that the target 
sample would be set at two treatment groups of 12 people each i.e. 24 participants in the 
experimental group and 24 participants in the control group, meaning the study aimed to recruit a 
total of 48 participants. After a five-month recruitment period, the total number enrolled into the 
study was 39 and the decision was made to initiate the study based on the minimum sample size of 
28 participants having been obtained.  
3.4 Measurements 
As participants were from various cultural groups, all instruments were made available to 
participants in English, Afrikaans and isiXhosa, the dominant languages of the region, to maximise 
participation. For clarity sake, the following measurements were evaluated. 
• Pain was the primary outcome of the current study and the measurement tool chosen was 
the BPI. The two sub-scores on the BPI were used to measure pain severity and pain 
interference (Appendix B). 
• Disability was a secondary outcome and was measured using the WOMAC. The WOMAC 
includes pain, stiffness and function sub-scores (Appendix C). 
• The EQ-5D-5L was used to measure health-related quality of life as a secondary outcome 
(Appendix D).  
• Function was also used as a secondary outcome and was measured using the ALF (Appendix 
E). 
• The TSK was used to assess fear of movement in participants as a secondary outcome 






The study received ethical approval and once the sample for inclusion had been established, as 
explained above, measurement instruments were piloted using 10% of the sample (four 
participants) to establish intra-rater and inter-rater reliability, as well as to allow the researcher to 
address any logistical issues or issues of understanding for participants. No issues were noted during 
the pilot study, and the full study commenced. A random sample was taken from the TKA waiting list 
at TBH using random number selection. Patients selected in the random selection process were then 
contacted telephonically to explain the nature of the study, offer them the opportunity to ask 
questions and invite them to participate (Appendix G). Upon verbal indication of willingness to 
participate over the phone, they were then screened for suitability for inclusion in the study. Using a 
questionnaire (Appendix H), the researcher performed an initial telephonic screening to exclude 
those who met any of the exclusion criteria.  
Patients fulfilling inclusion criteria for the study and none of the exclusion criteria as per the 
questionnaire, were invited to meet with the researcher or the research assistant, as well as an 
interpreter (where necessary) at TBH. Unfortunately over the course of the study and due to 
unforeseen circumstances, the research assistant changed several times. In total there were five 
different assistants who were all recruited through the UCT Department of Physiotherapy. Three of 
the five were qualified physiotherapists, the fourth was a final year physiotherapy student, and the 
fifth had a BA (Hons) in medical anthropology and a BA in health care studies with extensive 
research experience. Of course this may have impacted the accuracy of the information gathered, 
but all of them were trained in using the outcome measures chosen for the study before they 
commenced so as try and minimise this impact.  
At the first meeting, the study was explained in full and participants, as well as any family members 
or caregivers in attendance, were encouraged to ask questions to ensure that all involved had a 
thorough understanding of what taking part in the study entailed. Patients who wished to consider 
their involvement before committing were given the opportunity to go home and think it through, 
with the option of telephoning the researcher to inform them of their decision. Once participants 
had agreed to take part, and on condition that they met all the inclusion criteria and none of the 
exclusion criteria on further screening at TBH, written informed consent was obtained (Appendix I) 
and initial measurements were performed. Patients who were excluded over the phone or at initial 
meeting at TBH, or declined participation in the study, but wanted to receive usual care 
physiotherapy were offered a referral for physiotherapy at their nearest clinic. An exercise screening 
test was conducted by the researcher or research assistant, using the ACSM guidelines on 
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participants at initial meeting at TBH if there was concern regarding their ability to exercise safely 
(Appendix J). If there was concern in completing the ACSM, a six-minute walk test was performed to 
further evaluate suitability for inclusion.  
The study procedure is illustrated in Figure 4. Due to logistical and financial constraints, initial 
baseline measurements were taken at the time of recruitment. Participants were assisted in filling 
out the required questionnaires, with the researcher or research assistant (and interpreter where 
required) offering clarity on any misunderstanding or misinterpretation of questions. Interpreter 
bias was reduced by utilising tools which use numerical data. At this point it was noted that it was 
important to reassure participants that there was no correct answer and that the only person 
looking at the results would be the researcher, as some participants were hesitant in answering the 
questions. The research assistant was present at all follow-up sessions to provide assistance as 
needed by participants. 
After recruitment, participants were randomised by the researcher into a control group and 
experimental group using computer-generated, random number allocation. Participants were 
informed of the importance of the research assistant remaining blinded in the study to ensure that 
they did not reveal their group assignment at follow up sessions and compromise the integrity of the 
data gathered. Those allocated to the control group received no new intervention, but continued to 
receive their standard pharmacological and non-pharmacological treatment whilst on the 
arthroplasty waiting list, as decided by their treating doctor.  
The intervention group continued to receive the standard pharmacological and physical intervention 
they had been receiving prior to the study commencing, as well as beginning the six-week exercise 
and education intervention provided by the researcher, a qualified physiotherapist, trained and 
experienced in delivering the intervention. Patients received a workbook which was used by the 
researcher to teach and ensure understanding of the content 
(https://open.uct.ac.za/handle/11427/12697). Measurements were taken from both groups once 
the intervention had been completed at six-weeks. Patients then continued to wait for their surgery 
(which was scheduled to be done in the next three months). 
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On admission, prior to undergoing surgery, measurements were repeated as well as within a week of 
discharge from hospital. Following this, measurements were taken at six weeks post-surgery and 
final measures were taken three months post-surgery. 2  
                                                          









The intervention was the same as that used in a previous pre-operative study performed at TBH on a 
similar population of patients on a waiting list [29].  
As discussed in the literature review, the classes were held for two hours, once a week for six weeks. 
Refreshments of tea, coffee, water and biscuits were provided at every session. An isiXhosa 
interpreter was required for the one intervention group, and attended all six sessions to provide 
translation for participants during these sessions. The first class was run as a group of 12, and the 
second as a group of seven. Unfortunately, attendance was inconsistent in the first group, with some 
participants attending less than half of the sessions and no excuses being made for not attending. 
These participants were followed-up after missed sessions and reminded to please attend the 
following sessions. The second intervention group had less absenteeism and participants seemed to 
try very hard to attend and provided valid reasons if they were unable to attend or running late.   
Participants were not required to keep a log of exercise or physical activity during the six-week 
intervention, as the focus of the study was not on exercise levels, but on post-operative pain and 
function. Some participants did choose to keep track of their activity levels using their goal setting 
sheets as it helped them to monitor one aspect of their progress. On completion of the course 




3.7 Statistical analysis 
Data were analysed using Statistica software [145]. A clinically significant reduction in pain (a change 
in pain of more than 3 out of a possible 10 on a numerical rating scale) was used to classify 
treatment as successful or unsuccessful. Due to the small sample size, non-parametric analysis was 
done and results are presented as median and range throughout. The Mann-Whitney U and the Chi-
squared (χ2) tests were used to determine differences in socio-economic, demographic and clinical 
characteristics of the experimental and control groups. The Mann-Whitney U was used to analyse for 
change in prevalence of pain between groups. The effect of the intervention on pain within group 
was analysed using a one-way analysis of variance (ANOVA).  Effect sizes were calculated between 
groups where appropriate, using Cohen’s D3 with 95% confidence intervals. The following formula 
was used: ES = 
𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙 𝑚𝑒𝑎𝑛 𝑐ℎ𝑎𝑛𝑔𝑒−𝑐𝑜𝑛𝑡𝑟𝑜𝑙 𝑚𝑒𝑎𝑛 𝑐ℎ𝑎𝑛𝑔𝑒
𝑝𝑜𝑜𝑙𝑒𝑑 𝑏𝑎𝑠𝑒𝑙𝑖𝑛𝑒 𝑆𝐷
. Analysis was by intention to treat with 
missing data managed by carrying forward the last observed measurement.  Statistical significance 
was accepted as p≤0.05.  
3.8 Ethical considerations 
Ethical approval was granted by the University of Cape Town, Faculty of Health Sciences Human 
Research Ethics Committee (HREC Ref: 651/2015) (Appendix K), as well as the Western Cape 
Department of Health and TBH (Ref: 651/2015) (Appendix L). Subsequent amendments were also 
approved (Appendix M). This study upheld the Declaration of Helsinki, regarding the ethical 
principles of beneficence, non-maleficence, autonomy and justice [146]. Patients contacted were 
given an outline of the study and intervention, as well as any possible benefits or risks associated 
with participating in the study. Participants were given the opportunity to give a verbal indication of 
willingness to participate over the phone, followed by written informed consent, in their preferred 
language, on meeting with the researcher or RA. It was also clearly explained to the participants that 
they may withdraw from the study at any time, for any reason at all, without experiencing any 
penalty or negative effect on their usual care, with some patients choosing to do so. Any questions 
were answered before informed consent was signed.  
  
                                                          
3 Cohen’s D is an estimate of size of effect. 0.2 is a small effect size, 0.5 is moderate and 0.8 is large, 
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Studies mentioned previously have shown that exercise and education-based interventions have 
positive results on patients’ symptoms and further research should be conducted to explore post-
operative outcomes. These positive changes are what the researcher aimed to reproduce and as 
such maintain beneficence and non-maleficence in this study. The aim of the programme was to 
benefit participants by educating them about their condition and improving coping skills, as well as 
educating them about exercise and how they could be active. A further benefit was that with 
exercise they could become fitter and stronger, thereby improving their ability to cope physically 
with everyday tasks.  
There are risks associated with exercise, however these were minimised or eliminated as far as 
possible. Intervention sessions were led by a qualified physiotherapist, and potential participants 
were screened according to the ACSM guidelines for exercise participation to ensure safe 
participation in the intervention. Participants were warned that post-exercise stiffness or soreness is 
normal and may occur, especially for those unaccustomed to exercise. This was managed as best as 
possible by establishing a good, accurate baseline from which exercise was built up in the sessions. 
Provision was made so that if, during the course of the study, any participant experienced an 
unacceptable increase in pain they could be referred for physiotherapy assessment and treatment, 
as well assessment and pharmacological management by the attending doctor. Their participation 
would then be reassessed, either adjusting their exercise as necessary or removing them from the 
study completely. Participants were advised that should anyone become medically unstable during 
the course of the intervention, and therefore unfit for participation in an exercise programme, they 
would be removed from the study for their own safety and managed further by the attending 
doctor. 
Participation in the study, regardless of group allocation, had no effect on their usual care and 
patients in both groups continued to attend their usual follow-up visits, with the addition of the 
researcher testing visits. Their place on the arthroplasty waiting list was potentially positively 
affected to facilitate study completion, however patients were not informed of this potential so as 
not to coerce them into participating. Should this programme be shown to be successful, 
recommendations will be made that patients on waiting lists receive this intervention in future, 




Confidentiality was maintained by the researcher, by allocating each patient a code and therefore 
not using any names for the recording of results. Results cover the group responses and nothing that 
would make a participant identifiable is shared. Furthermore, participant data was stored on an 
external password protected device, and locked away when not in use, so as not to compromise the 
identity of the participants. All participants were required to sign a confidentiality agreement when 
signing informed consent to ensure that if they were randomised into the intervention group they 
kept the identities and details of fellow group members confidential. The researcher can never 
guarantee absolute confidentiality as that relies on group members themselves. Therefore, all 
participants were made aware of this fact and the need for taking confidentiality seriously was 
emphasised. Patients did not receive any payment for participating in the study and as such any 
coercion was avoided. Due to financial constraints on the study, the cost of transport to and from 
the intervention sessions, and the measurement sessions could only be partially subsidised, and 
every attempt was made to perform measurements on days when the participants were attending 
the hospital to make use of other services. 
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Chapter 4: Results 
The Consolidated Standards for Reporting Trials (CONSORT) [147] diagram below illustrates the 
study process from enrolment of participants to analysis of the data (Figure 5). 
 





4.1 Socio-demographic profile of participants 
Socio-demographic information was gathered using a simple questionnaire (Appendix O). The study 
participants (N=27) were randomly divided into the control (n=13) and experimental (n=14) groups. 
The median age of the sample was 63 years (54-70). There was no significant difference between the 
groups for age [61.5 (54-69) vs 63 (55-70); U=76.5; p=0.5]. 
There were no significant differences between groups for home language, sex, level of education, 
employment and time on the waiting list (Table 3). The majority of the participants were female 
(n=21), Afrikaans speaking (n=16) and unemployed (n=18) with a grade nine level of education or 
less (n=11).  
Table 3: Socio-demographic characteristics of the study participants (N=27) 





























Level of education    χ2=2.84; p=0.24 















































4.2 Pain severity and pain interference 
4.2.1 Pain Severity Score (PSS) 
The control group’s scores on the PSS were significantly lower than those of the experimental group 
at recruitment (U=49.5; p=0.05), post-intervention (U=33; p=0.01) and at 6-week post-operative 
follow-up (U=22.5; p=0.01). Both groups had a significant within group reduction in PSS over time 
(control group χ2=11.85; p=0.02 and experimental group χ2=10.54; p=0.03) (Figure 6). The effect size 
for the PSS was -0.23 (-1.06 – 0.61 95%CI)4 indicating no difference between groups.  
 
Figure 6: PSS for the experimental group and the control group from recruitment to three months 
post-operative follow-up 
                                                          



























































































































































































































4.2.1.1 Least pain 
The “least pain” scores were not significantly different between groups at recruitment, however the 
control group had significantly better least pain scores at both immediate post-operative follow-up 
(U=33; p=0.01) and at six weeks post-operative follow-up (U=19.5; p=0.01). The control group 
improved significantly over time (χ2=11.25; p=0.02), whilst the experimental group got significantly 
worse over time (χ2=10.57; p=0.03). The effect size for the “least pain” score was -0.53 (-1.36 – 0.34 
95%CI) indicating no difference between groups. 
4.2.1.2 Pain right now 
The “pain right now” scores were not significantly different between groups at recruitment. Scores 
for the control group were significantly better than those of the experimental group at post-
intervention (U=33.5; p=0.01), six weeks post-operative (U=20.5; p=0.01) and three months post-
operative follow-up (U=25.5; p=0.02). Both groups showed significant improvement over time 
(control group χ2=10.99; p=0.03 and experimental group χ2=10.51; p=0.03). The effect size for the 
“pain right now” score was -0.45 (-1.48 – 0.41 95%CI) indicating no difference between groups. 



























































































































































































4.2.1.3 Worst pain 
“Worst pain” scores for the control group were significantly lower than those of the experimental 
group at recruitment (U=31.5; p=0.05). Both groups displayed a significant within group reduction in 
their “worst pain” scores over time (control group χ2=13.31; p=0.01 and experimental group 
χ2=18.56; p=0.01) (Figure 7). The effect size for the “worst pain” score was 0.37 (-0.49 - 1.2 95%CI) 





















Figure 7: "Worst pain" scores for the experimental group and the control group from recruitment to 
three months post-operative follow-up 
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4.2.1.4 Average pain 
The “average pain” scores for the control group were significantly lower than those of the 
experimental group at recruitment (U=44.5; p=0.03), post-intervention (U=28; p=0.05), post-
operatively (U=27; p=0.02) and at six weeks post-operative follow-up (U=26; p=0.03). Both groups 
experienced a significant within group improvement in their “average pain” score over time (control 
group χ2=9.3; p=0.05 and experimental group χ2= 11.77; p=0.02) (Figure 8). The effect size for the 
















Figure 8: "Average pain" scores for the experimental group and the control group from recruitment 













































































































































































Table 4 shows the median and range of scores on the “worst pain” and “average pain” items of the 
BPI for each group, comparing the differences at each data collection point and indicating where 
there were significant differences between groups by means of an asterisk (*). 
Table 4: "Worst pain" and "average pain" scores for the control group and the experimental group 
from recruitment to three months post-operative follow-up (median and range used as measures of 


































































4.2.2 Pain Interference Score (PIS) 
Scores on the PIS were significantly lower for the control group than the experimental group at both 
recruitment (U=50; p=0.05) and at 6-week post-op follow-up (U=21.5; p=0.01). Both groups achieved 
a significant within group reduction in their PIS over time (control group χ2=12.81; p=0.01 and 
experimental group χ2=9.47; p=0.05) (Figure 9). The effect size for the PIS was  
0.02 (-0.82 - 0.85 95%CI) indicating no difference between groups. Table 5 shows the change in PSS 































































































































































































































































Table 5: PSS and PIS for the control group and the experimental group from recruitment to three 




































































4.2.2.1 Individual item scores on the PIS 
The control group achieved significant improvement over the experimental group at six weeks post-
op on five of the seven items on the pain interference scale [general activity (U=28; p=0.04), walking 
ability (U=22.5; p=0.02), normal work (U=15; p=0.01), relations with others (U=21; p=0.01), and sleep 
(U=19; p=0.01)]. They also showed significant improvement over the experimental group on the 
normal work item at post-intervention (U=44.5; p=0.04) and post-op measures (U=27.5; p=0.04), and 
on the enjoyment of life item at post-intervention follow up (U=45.5; p=0.05).  
The control group achieved significant improvement over time on the items of general activity 
(χ2=15.25; p=0.01), walking ability (χ2=10.33; p=0.04), relations with others (χ2=10.17; p=0.04), and 
sleep (χ2=9.92; p=0.04). Although significantly worse than the control group on almost every item in 
the PIS, the experimental group showed significant within group improvement over time on three of 
these [general activity (χ2=10.02; p=0.04), walking ability (χ2=9.67; p=0.05) and normal work 
(χ2=10.81; p=0.03)].  




4.3.1 WOMAC total score 
There was no significant difference between groups at any point in time. Both groups achieved a 
significant improvement on the WOMAC at three months post-op follow up (control group χ2=11.71; 
p=0.02 and experimental group χ2=14.19; p=0.01) (Figure 10). The effect size for the total score was 
















Figure 10: WOMAC total score for the experimental group and the control group from recruitment 














































































































































































4.3.1.1 WOMAC pain score 
As with the PSS, the control group had significantly lower levels of pain than the experimental group 
at recruitment (U=45; p=0.03). The control group showed a significant improvement over time 
(χ2=9.52; p=0.05), whereas the experimental group did not (χ2=8.47; p=0.08).  The effect size was 
0.02 (-0.82 – 0.85 95%CI) indicating no difference between groups. The data tables for this 




4.3.1.2 WOMAC stiffness score 
There were no significant differences between groups at any point in time. The experimental group 
achieved a significant change in stiffness over time (χ2=16.47; p=0.01), but the control group did not 
(χ2=6.92; p=0.14). The effect size was 0.72 (-0.17 – 1.55 95%CI) indicating no difference between 





















Figure 11: WOMAC stiffness score for the experimental group and the control group from 









































































































































































































4.3.1.3 WOMAC function score 
There was no significant difference between groups at any point in time. Both groups showed a 
significant improvement at three months post-operative follow up (control group χ2=10.1; p=0.04 
and experimental group χ2=12.91; p=0.01) (Figure 12). The effect size was 0.44 (-0.42 – 1.27 95%CI) 

















Figure 12: WOMAC function scores for the experimental group and the control group from 









































































































































































































4.4 Health related quality of life (HRQoL) 
4.4.1 The EQ-5D-5L 
There were no significant differences between groups on the VAS of the EQ-5D at any point in time 
during the study, and neither of the two groups achieved a significant within group change to their 
VAS rating of health-related quality of life over the study period (control group χ2=7.87; p=0.09 and 
experimental group χ2=3.2; p=0.52). The effect size was -0.45 (-1.28 – 0.41 95%CI) indicating no 
difference between groups. 
The mobility section of the EQ-5D-5L assessed for degree of difficulty in mobility. The graphs below 
show the changes in the mobility scores, with the numbers in both groups reporting inability or 


















Figure 13: EQ-5D-5L mobility scores for the experimental group and the control group from 
























Recruitment Post-intervention Post-op Six weeks post-op Three months
post-op
Experimental group
None Slight Moderate Severe Unable Missing
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The usual activities section of the EQ-5D-5L assessed for the degree of difficulty associated with 
conducting usual activities for the participant. The graphs below show the change in usual activity 
scores over time (Figure 14). There was more variation of scoring evident in the experimental group 


















Figure 14: EQ-5D-5L usual activity scores for the experimental group and the control group from 









Recruitment Post-intervention Post-op Six weeks post-op Three months
post-op
Experimental group
None Slight Moderate Severe Unable Missing
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The graphs below show the change over time in scores on the pain/disability section of the EQ-5D-5L 

















Figure 15: EQ-5D-5L pain/discomfort score for the experimental group and the control group from 
recruitment to three months post-operative follow-up 
 
The three aspects of the EQ-5D-5L presented above link most closely with the parameters being 
assessed in the other outcome measures and as such are presented here. The self-care and 


























None Slight Moderate Severe Extreme Missing
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4.5 Function  
4.5.1 The Aggregated Locomotor Function Score (ALF) 
There was no significant difference between the groups on the ALF at any point. The experimental 
group improved significantly over time (χ2=17.73; p=0.001), whereas the control group showed no 
significant change (χ2=7.2; p=0.13) (Figure 16). The effect size was -0.26 (-1.09 – 0.59 95%CI) 
indicating no difference between groups.  
Figure 16: ALF scores for the experimental group and the control group from recruitment to three 


















































































































































































































4.6 Fear of movement 
4.6.1 TSK scores 
Both groups achieved a significant within group improvement over time on their TSK scores (control 
group χ2=10.88; p=0.03 and experimental group χ2=13.24; p=0.01). The experimental group showed 
significant improvement over the control group post-intervention, with a lower TSK score (U=42; 
p=0.03) (Figure 17). The effect size was 1.39 (0.41 – 2.26 95%CI) indicating a difference between 















Figure 17: TSK scores for the experimental group and the control group from recruitment to three 





















































































































































4.7 Summary of results 
Although the current intervention may have been beneficial in a previous study on a similar 
population while waiting for an arthroplasty [29] the current study’s results suggest that the benefits 
experienced while on a waiting list may not be incurred when patients know that their surgery is 
imminent nor impact post-operative outcomes. The results were mixed but suggest that for every 
outcome measure, excluding the TSK, there was no difference between the two groups at three 
months post-operative follow-up when effect sizes were calculated with a 95% CI. The TSK was the 
only tool which indicated a difference at three months post-operative follow-up, with the 
experimental group achieving significantly better results than the control group. 
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Chapter 5: Discussion 
The aim of this study was to evaluate the effects of an exercise and education based intervention on 
post-operative pain and function for patients with knee OA, awaiting TKA at Tygerberg Hospital in 
the Western Cape. The intervention employed in the current study had been used successfully in a 
previous study conducted on the same population on an arthroplasty waiting list [29]. The previous 
study did not assess post-operative outcomes, thus the current study aimed to assess post-operative 
pain and function outcomes in patients undergoing TKA.  Overall, results suggest that the pre-
operative intervention did not influence post-operative outcomes and there were no differences 
between groups at the three-month post-operative follow-up, except for the results of the TSK, 
which was used to measure fear of movement as a secondary outcome. The study was not powered 
for the fear of movement results, but the experimental group achieved significant improvements 
compared to the control group in this aspect of testing. These results, relating to pain and function, 
are not consistent with the previous research in a similar population [29], however it is important to 
note that the focus of the previous study was whether benefits were achievable prior to surgery. 
This leads one to question not only the appropriateness of the intervention itself in terms of 
achieving post-operative benefits, but also of the measurement tools used for this study.  
From these results, there are some useful insights and interesting points are raised which warrant 
further discussion. The specific difficulties associated with conducting research in a public health 
setting in South Africa on a population waiting long periods for surgery, and how it differs from 
previous research are discussed. Possible improvements to the intervention to make it more 
appropriate for use in this group (who are aware that their surgery is imminent) are discussed to 
assist with formulating interventions for future research and clinical application. 
To provide context and evaluate generalizability of the results, the socio-demographics of the 
participants in this study will be compared to and contrasted with those of participants in other 
studies of this nature, as well as the global socio-demographics of patients undergoing TKA for OA. 
This will be followed by a review of the measurement tools used, and the appropriateness thereof. 
Factors influencing non-participation and the large amount of missing data will also be considered, 
as well as potential explanations for seemingly conflicting results. Finally, the strengths and 
limitations of the study will be discussed, including recommendations regarding practical changes 
and improvements to the intervention to make it more appropriate for this group of patients. 
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5.1 Socio-demographic profile of the participants 
The socio-demographic characteristics of the participants were similar to those in the study 
conducted by Saw et al (2015), which is not unexpected, given that the study was conducted in the 
same setting.  
Levels of education in the population were low, but consistent with those reported in the 2016 
South African community survey conducted by Statistics South Africa, which reported that the 
majority of survey respondents had some secondary schooling, but have not completed Grade 12 
[30]. The percentage of unemployed participants in the present study was 66.66%, which is much 
higher than the 27.7% reported by Statistics South Africa [148]. This high level of unemployment 
may be due to the setting, or as a result of the sample population used. The study was conducted in 
a state hospital in South Africa, a country where 84% of the population rely on the national health 
sector for the sole provision of their healthcare needs [21]. Given that this is the uninsured portion 
of the population [21], it might make sense to assume that their levels of unemployment would be 
higher than if one were to take into account the national population, including the 16% of South 
Africans who have health insurance. The study being conducted on participants with a median age of 
63 years and the inclusion of patients over 65 years of age, which, although not legislated, is widely 
accepted as retirement age in South Africa [149] may have also influenced the reported levels of 
unemployment. 
The age range of patients undergoing TKA or total hip replacement, according to a large systematic 
review by Ethgen et al (2004), was 41 years to 73 years old [150]. The current sample is similar in 
that the median age falls within this grouping. As was the case in the interventions reviewed, 
patients in the present study had a mix of diagnoses with those with OA and RA being placed in the 
same groups, with the outcome of the surgery being the point of focus, not necessarily the disease 
mechanism. The similarities in age and disease profile makes comparison of results possible, 
however, many of the previous studies assessing patients with OA and those having TKA have been 




5.2 Outcome measures  
5.2.1 Pain 
The primary outcome of the study was pain. In this study, the intervention did not produce an effect 
on pain severity or pain interference in this sample. Analysis of the results from the study and 
evaluation of the responses to the questionnaires themselves led to questions regarding the 
suitability of the assessment tool for this group. Although the research assistant was present at all 
data collection points and available to help with the completion of the questionnaires, there were a 
number of data collection points where the responses provided suggest a lack of understanding of 
the questions being asked, which may have affected the accuracy of the results e.g. in several 
instances every single item on the BPI was scored as a zero and all options on EQ-5D-5L were crossed 
off for each category. This is surprising given that the tool has been translated and validated for use 
in all three languages encountered in the sample group [113]. The effects of low levels of education 
and health literacy and how these relate to the current study will be discussed later.  
Although there was no significant improvement by the experimental group over the control group 
on either of the sub-scales of the BPI, both groups experienced a reduction in their pain severity and 
interference scores following their surgeries. This suggests that the surgery alone was successful in 
reducing pain and that although the experimental group in the study by Saw et al (2015) showed 
promising results in a waiting list population, those same effects were not achieved in a group 
undergoing surgery soon after intervention. The sensitivity of the BPI to a change in pain in this 
group may then suggest that the lack of positive result from the intervention may be a combination 
of factors. One factor worth considering is that the control group scored significantly better than the 
experimental group on the both PSS and PIS at recruitment and thus perhaps the lack of positive 
result from the study was simply that the experimental group had too much ground to make up in 




The above being considered, there were still clear instances of misunderstanding of the tool and 
how to complete it. Having defined pain as more than simply a unidimensional experience [26], it is 
impossible to assess using a tool which doesn’t take this into account. As such, in future studies on 
similar populations or where literacy is a concern it may be useful to provide participants with 
training on how to complete the required questionnaires, before they have to do so or use the 
questionnaires by interview. Another option may be to provide a new and thorough explanation as 
to how to complete the questionnaires at every single follow-up session. The current study assumed 
that the participants would grow familiar with the tools and as such would not require fresh 
explanation at every follow-up. Given what is now known regarding literacy levels and their health 
literacy that may have been an assumption too far. It may be time consuming to implement these 
suggestions, but by reducing the room for error, it may ultimately improve the validity of the 
findings. 
5.2.2 Secondary outcome measures 
The same lack of significant change between groups was evident on the WOMAC, EQ-5D-5L and the 
ALF. These measures did not reveal any difference between the two groups. 
5.2.2.1 The WOMAC 
The WOMAC, much like the BPI revealed within group changes over time, with both groups 
improving. The findings for the experimental group were consistent in that both their WOMAC 
function score and their ALF score improved concurrently, whereas the control group showed 
improved scores on WOMAC function, but not on the ALF. This is surprising as one would assume 
that as self-reported levels of function improved, so should observed measures of function. As with 
the BPI, the control group had a significantly better starting point at recruitment than the 
experimental group, and showed significant improvement over time. Ultimately there were no 
differences found between the groups on the WOMAC total score or any of the sub-scores at three 
months post-operative follow-up as was the finding with most of the other outcomes in this study. 
As is suspected with the BPI, there may have been issues of understanding related to this tool. It 
may have also been inappropriate for this particular group, with several participants struggling to 




5.2.2.2 The EQ-5D-5L 
As discussed in the literature review, the EQ-5D-5L has not been validated for this sample, however 
the 3L had been validated. It was expected that the 5L, although not validated would still be suitable 
for use and would be more sensitive to change over time in this group [135].The scores on the VAS 
of the EQ-5D revealed no change between groups or within groups, however there were issues 
encountered regarding the completing of this section by the participants, as much like the BPI, the 
numerical rating scale seemed confusing for some. Once again, the instrument showed within group 
changes, but significance was not established due to the nature of the data, with no norms available 
for the South African population nor formulae for converting the data to numerical values. Notably 
on the EQ-5D-5L there were a lot of missing data, particularly in the final data collection period. This 
was a consequence of a number of participants failing to follow-up. But this may have been 
compounded by difficulty in completing the questionnaire. Once again, participants may have 
benefited from some training or repetitive explanation on how to complete the questionnaire or the 
questionnaire should have been administered by interview. In future, it may be advisable to use the 
3L, despite its limited sensitivity to change over time as it is less complex to complete, has normal 
values and formulae to convert to numerical data.   
5.2.2.3 The TSK 
The TSK was the only tool indicating any meaningful change over time. This result is interesting, 
considering the lack of change on any of the other outcome measures and will be discussed in the 
following section within the context of pain and fear and how they influence behaviour.  
5.3 Pain and Fear 
The lack of clinically meaningful change on the BPI as well as the WOMAC, coupled with the 
reduction in fear of movement revealed on the TSK provide an interesting area to explore. This is 
noteworthy because it suggests that even though participants experienced little difference in both 
the changing of their pain severity and disability, fear of movement in the experimental group 
reduced significantly. Based on a biomedical model of pain [151] one might assume that fear of 
movement would only become less if pain severity were reduced, thus these findings would appear 





The biopsychomotor-model of pain postulates that pain is a multi-dimensional system and differs 
from the biopsychosocial model in that behaviour is a defining and central feature and is not simply 
a result of cognitive, social or emotional influences[152]. In the paper by Sullivan (2008 p. 282), pain 
behaviour refers to “specific body movement enacted during the experience of pain” [152]. “Such 
movement might include facial or postural configuration, actions oriented toward protection or care 
of an injury, and actions oriented toward the pain-related stimulus or pain-relevant environment” 
[152]. Communicative behaviours are an integral part of the pain system and verbal responses are a 
major aspect of these communicative behaviours [152]. Although the current study made use of 
questionnaires with specific rating scales, these could still be considered opportunities for 
communicative behaviours relating to pain as they provide an opportunity for the individual to 
express their suffering experience. 
Thus, using the biopsychomotor model, it could be suggested that because these individuals are less 
fearful of movement (potentially performing more physical activity than they may have previously), 
they may feel the need to verbally express their pain “more loudly” in order to convey their suffering 
and have it recognised and understood. Thus, they show no change in their pain reports, despite a 
change in their beliefs around movement. What this may not explain is the lack of change on the 
WOMAC scores, as based on the fear-avoidance model put forward earlier, fear avoidance beliefs 
should influence behaviour, thereby reducing disability [72]. This leads one to the question of 
whether changing beliefs alone is enough to bring about a sustainable change in behaviour. The 
results of this study suggest that the answer is no, changing beliefs will not result in sustainable 
changes in behaviour. If this is the case, there are factors influencing behaviour change and thereby 
a reduction in disability which require further consideration. Such factors include self-efficacy and 
social learning.  
Self-efficacy was not an outcome in this particular study, however looking at the results and the 
demographic profile of the participants, one might consider that low levels of self-efficacy may have 
played a role in limiting change in disability in these patients, despite the change in fear of 
movement. Although the fear-avoidance model suggests that fear-avoidance beliefs are an 
important mediator of disability, one of its shortcomings is that it does not appear to take into 
account the influence of self-efficacy in the process of behaviour change [72]. There is growing 
evidence to suggest that self-efficacy is an important mediator of the relationship between fear-
avoidance beliefs and disability [153, 154]. This evidence suggests that without adequate levels of 
self-efficacy, an intervention such as the one offered in the current study is unlikely to be successful 
in changing disability, or the behaviour of those patients receiving it. Figure 18 below shows the 
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modified Fear-Avoidance Model developed by Woby [154], which includes self-efficacy and 
illustrates the effect it has on the relationships between beliefs and behaviour change.  
 
 
Figure 18: Woby's fear-avoidance model [154] 
Self-efficacy, as already discussed, relates to an individual’s confidence in their own ability to 
execute a behaviour in order to achieve an outcome [97]. Based on Bandura’s self-efficacy theory, it 
depends on four factors, namely: performance accomplishments, vicarious experience, verbal 
persuasion, and physiological states [97]. These vicarious experiences in particular are important as 
social learning opportunities. Bandura suggests that by watching a peer engage in an activity which 
is feared by the individual, and seeing that there is no negative consequence encountered, that 
individual’s fear may be alleviated, which should guide their actions to less fearful behaviours [155]. 
In a tertiary health-care setting, patients engage with others who are not from their immediate 
community and whom they may not identify with; essentially the opportunity for peer-learning may 
be reduced. It may thus be postulated that a lack of common identity, limited the potential for social 
learning to take place in the experimental group, and hindered the development of adequate self-
efficacy to effect a change in behaviour. 
As mentioned in the introduction to this section, the results of this study suggest that changing 
beliefs does not always change behaviour. The role of self-efficacy in mediating behaviour change 
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has been broadly accepted; however, the important roles of social cohesion and social learning in 
the process of enhancing self-efficacy may be more complex. Social learning would appear to be a 
major driver of behaviour change through the development of self-efficacy in group interventions. If 
there is no social cohesion, one may expect that social learning will not take place. It has been 
proposed that there is a minimum requirement for the level of social cohesion needed to gain 
positive health effects [156], further supporting the notion that it is an important determinant of 
whether or not social learning will take place.  In future, consideration of factors which increase 
social cohesion needs to be made when allocating patients to groups for interventions such as the 
one used in this study. This has been previously recommended in groups for managing pain in 
people living with HIV with consideration made for  age, gender and cultural group to enhance 
cohesion and provide a common identity amongst patients [103]. In looking at the factors 
surrounding the development of self-efficacy, and facilitating behaviour change and social learning, 
one may look to the strengths and limitations of the study to assess how things may be done better 
in future research and clinical practice. 
5.4 Limitations and Strengths 
5.4.1 Limitation: Inconsistent research assistance 
Logistics surrounding research assistance in this study proved challenging. As the primary researcher 
was only able to perform the intervention and not the data collection due to blinding constraints, a 
research assistant had to be used. Unfortunately, the research assistant changed several times 
through the course of the study. Though training was done on how to administer the measures, it is 
possible that the lack of continuity affected the results.  
5.4.2 Limitation: Non-participation 
The study encountered many problems with recruitment of participants and target numbers for 
recruitment were not met. There were a large number of individuals who were on the waiting list, 
however when telephonic contact was attempted, they were unable to be reached. Of those 
contacted telephonically, approximately one fifth of those were uninterested in participating in the 
study. These challenges were not dissimilar to those of a previous study conducted at the same 
hospital on patients on the arthroplasty waiting list [29]. The greatest challenge was the participants 
who enrolled in the study and then could not be contacted (or agreed to come and did not arrive), or 
those who had received their surgery and then simply failed to arrive for their follow up.  
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The other big challenge regarding non-participation was poor attendance of the group intervention. 
As already mentioned, some members of the first group attended less than half of the sessions. This 
obviously poses a challenge when trying to assess to the effect of an intervention which is not 
received in its entirety. 
Due to the fact that this study assessed post-operative outcomes, the number of participants lost 
may have been slightly higher than if it was only assessing pre-operatively. In a setting such as the 
current one, where patients have waited for several years to have their surgeries, and hospital 
resources are limited and inconsistent, the constraints involved need to be taken into account and 
possibly a larger sample should have been considered to allow for greater loss to follow-up. As seen 
in the results (Figure 5), there were a number of unforeseen circumstances leading to exclusion and 
therefore loss of participants. These included: the patient being scheduled for the incorrect surgery; 
patient not being able to have their surgery in time (according to the patient, as informed by the 
hospital, this was due to an inconsistent electrical supply to theatres, and back-up generators not 
working properly, making it unsafe to perform surgery); patients deemed unfit for surgery only at 
pre-operative assessment; and patients being scheduled for their other limb to have arthroplasty, 
which given the waiting time, they could not be expected to pass up for the sake of completing a 
study.  
As a result of withdrawal, exclusion and loss of several participants during the course of the study 
the sample size was small and therefore the study lacked the numbers needed to be adequately 
powered. This may mean that future studies will require larger samples in order to yield 
generalizable results. Aside from the obvious logistical problems associated with the hospital and 
processes related to the waiting lists, some suggested reasons for non-participation are discussed in 
the following sections. 
5.4.2.1 Loss of Social Cohesion 
In a paper by Stanley (2003), social cohesion is defined as “the willingness of members of a society to 
co-operate with each other in order in order to survive and prosper”[2]. The definition of Social 
Cohesion proposed by Chan et al (2006), providing perhaps a more thorough understanding, is “a 
state of affairs concerning both the vertical and the horizontal interactions among members of 
society as characterized by a set of attitudes and norms that includes trust, a sense of belonging and 




An understanding of the history of segregation and oppression in South Africa may help to explain 
the lack of social cohesion that this country still experiences today. Apartheid was used to create a 
society divided along racial lines and using the Group Areas Act, the government of the time 
managed to force people to live only with those of the same allocated race group [158]. This may 
have increased social cohesion within each race or even cultural group, however it created division 
between groups, which is still felt today [159]. As discussed earlier, this lack of intersectional 
cohesion may have reduced the potential for social learning within the experimental group during 
the intervention period as groups included participants from various cultural backgrounds and 
differing communities and in doing so may have limited the ability of the intervention to achieve the 
desired outcomes [156]  
There were several participants who enrolled in the study who failed to participate adequately, 
attending less than four group sessions (for the purposes of the study) with no reason given for 
those sessions missed, and others who made other plans for the time allocated to the sessions. 
Using the definition of social cohesion above, one could suggest that this may have to do with a lack 
of social cohesion in the sample population. Understandably, these patients had all been on the 
waiting list for some time and probably would have done almost anything to receive their surgeries 
in a more timeous fashion. Once they were made aware that they would get their surgeries in the 
following three months, it became quite clear that for a few of them, they had received what they 
needed from the study. It should be noted that commitment to the full six weeks was emphasised at 
recruitment, in an attempt to prevent this problem, but obviously participants could not be forced to 
arrive at appointments and given the levels of unemployment in the participants, perhaps poverty 
contributed to lack of participation. 
5.4.2.2 Poverty 
Lack of finances for transport was a common problem experienced throughout the study, making it 
difficult to gather data. The majority of this sample was unemployed and the researcher could only 
provide transport money once the participant arrived at the hospital to complete their measures. 
This made it difficult for those who were willing, but financially unable to get to the hospital to 
collect their money. Solutions to this problem may be quite difficult to work out as funding is often 
limited in the studies themselves and one cannot hand over money in anticipation of a transport 
need, as there is the possibility that the participant will still not attend and that money will not be 
used for its intended purpose. A possible option to be investigated would be making use of allocated 
private transport, which would bring participants to and from the hospital on the desired days. This 
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may prove to be more expensive than using public transport, however it may be more reliable in 
ensuring that participants arrive for measurement visits. 
Lower literacy levels [160], as well as lower levels of health literacy specifically [161] have been 
associated with poorer health outcomes. It may be that the initial low levels of health literacy were 
so severe that the intervention designed was not sufficient to change health outcomes. There was a 
high degree of educational poverty in this study. As a result, health-literacy in the present cohort 
may have been limited, possibly influencing the results negatively. Low levels of health literacy could 
negatively impact results in two ways, firstly due to the nature of the outcome measures used and 
secondly as a consequence of health literacy limiting interaction with the intervention. Although 
literacy was not assessed specifically in this study, it would be useful to do this in future research of 
this nature so as to provide the most appropriate assistance for participants when filling out 
questionnaires. 
With regards to the outcome measures, four of the five outcome measures used were self-report 
questionnaires requiring comprehension by the patient. Even with assistance, it became clear 
throughout the course of the study that there were gaps in understanding, with participants 
frequently asking questions to clarify meaning and appearing unsure about how to answer correctly. 
This may have been because even though the researcher attempted to make use of the simplest and 
yet most effective tools, the large number of questionnaires (four), may have increased the response 
burden on these patients. Potential solutions to dealing with this problem in future research have 
been discussed previously. 
In terms of health literacy limiting interaction with the intervention, a systematic review assessing 
the effectiveness of musculoskeletal education interventions on patients with low literacy levels, 
found that engagement with these patients was poor [162]. It has also been reported  that patients 
with low levels of health literacy may struggle to act on the information being given to them in a 
health education context [163]. This supports the notion that these patients would therefore 
struggle to achieve one of the main goals of the intervention, which is behaviour change, due to a 
lack of adequate engagement or an inability to respond appropriately. It may be valuable in future 
research to assess levels of health literacy and not only level of schooling completed to evaluate 
whether patients are able to engage with educational behaviour-change interventions  The 
intervention itself may also need to be addressed to make it more appropriate for populations with 




5.4.3 Limitation: The intervention 
The specific intervention and coursework book used in the present study has never before been 
used in a group where surgery is imminent. The studies making use of this intervention previously 
[29, 115] used it in patients who were awaiting surgery and did not know when (if ever) they would 
be offered the surgery. This is obviously very different to the current participants who knew that 
they would be receiving their surgery soon. A patient’s expectation about their treatment can affect 
the outcome positively or negatively [164]. Using this premise one could speculate that the patients 
in the previous studies by both Saw et al (2015) and Kruger-Jakins et al (2015) did well with the 
current intervention as they considered it their only option or solution. It is likely that their 
expectations were low as far as actually receiving their surgery was concerned, having been on 
waiting lists for up to five years. This in turn may have increased their expectations regarding results 
to be achieved using the group intervention, thus positively influencing the outcome of the study 
[165].  
In the current study, the participants were already anticipating surgery and so perhaps on a 
subconscious level, were not inclined to place as much hope on the intervention offered as it was 
perceived more as an interim activity which was a means to an end (that being surgery). This could 
potentially have influenced the degree to which they benefitted from the intervention [165]. 
The intervention used does not dedicate time to explaining the surgery or post-surgical pain. One of 
the key messages delivered in the intervention is that pain is not equal to tissue damage with 
exercise being safe despite pain. This message is not wrong, however it may appear contradictory 
and even confusing to those undergoing surgery who then experience post-surgical pain due to 
trauma to the body. Having been told that pain doesn’t mean damage in terms of the chronic 
osteoarthritis pain, patients may now have doubted that information or become confused when 
faced with the very clear evidence of pain in the presence of acute tissue damage following surgery. 
There is evidence to support iatrogenesis in chronic pain patients, with inappropriate information or 
advice causing anxiety and distress [166]. Taking into account the low levels of education and limited 
health-literacy of the sample, it may be that an intervention for a group who will be receiving their 
surgery soon after, should include surgical education and perhaps avoid creating confusion around 





In both of the previous studies evaluating the effect of this intervention in people living with OA, 
self-efficacy was assessed at baseline and six months follow-up, with no significant differences seen 
between groups [29, 115]. This leads one to question whether or not the current intervention 
addresses self-efficacy at all. If the intervention is not adequately addressing self-efficacy and 
patients are starting off with low levels of self-efficacy as is suspected in this instance, then 
behaviour change is likely to continue to fail. This, along with the suggested lack of common identity 
and reduced social learning in a tertiary setting, may render this intervention ineffective in a 
population undergoing TKA. It may be worth considering delivering this intervention in a primary 
healthcare setting, which is more community orientated, to patients who have been diagnosed with 
knee OA, but who are not due for surgery, or perhaps are not even on a waiting list yet. This may 
have the potential to yield better outcomes as the intervention message is consistent with self-
management and the setting will enhance social cohesion. 
5.4.4 Limitation: Post-operative follow-up care 
Due to post-operative rehabilitation being out of the study’s control, inconsistencies in the amount 
or timing of exercises done and functional rehabilitation done were possible. Follow up in the 
outpatient department was also generally done at six week follow up with the surgeon with no 
interim follow-up with any member of the team. This long period of time might be inadequate for 
those patients with high fear-avoidance beliefs around movement. In future, post-operative follow-
up care should be standardised for all patients involved. This would hopefully further validate results 
by removing variability in this area.  
 
Post-operative rehabilitation following TKA should seek to increase self-efficacy to facilitate 
behaviour change following surgery. When looking at “performance accomplishments” as a source 
of efficacy information, one could compare the four stages of performance accomplishments to a 
model for graded activity [97]. Rehabilitation following injury is essentially a graded activity 
programme with the patient being required to progress in load and difficulty as they improve. If this 
is done well following surgery and strategies to enhance self-efficacy (such as performance 
accomplishments and verbal persuasion) are employed, then maybe self-efficacy is being addressed. 
Interestingly, despite a number of factors mentioned above, which should have prevented these 
patients from enjoying positive post-operative outcomes, both groups improved. This improvement 
in both groups may have been as a result of the Hawthorne Effect. 
Despite the limitations experienced as a result of the cultural and socio-demographic diversity in this 
population, there were also several strengths.  
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5.4.4 Strength: Cultural practices 
South Africa is an ethnically and culturally diverse nation [167]. According to estimates from 2007, 
72% of the black African population in South Africa make use of traditional medicine [168]. During 
the current study, one participant completed the entire intervention and then, being given his date 
for surgery, he decided that a more traditional approach was preferable. Throughout the course of 
the intervention he had continued with his traditional interventions, but engaged fully with the 
content. Interestingly, it was only the surgery which he chose to abandon, and his respected position 
in the community put him in a position where he was motivated to take the new knowledge and 
skills gained from the intervention back into his community.  
Although the above-mentioned patient withdrew from the study to pursue traditional medicine 
options, his desire to continue with sharing his knowledge in his community raises an important 
point for future research and interventions being conducted in similar settings. Whilst a lack of 
intersectional social cohesion may have been a limitation of the study, the level of social cohesion 
within each community or social group should be considered and used to the benefit of that 
community. As mentioned earlier, the setting of the intervention should be considered. It may be 
more beneficial to deliver an intervention of this nature at a primary healthcare level, rather than a 
tertiary level. At primary health clinics, patients are more likely to be functioning within their own 
community. Perhaps an intervention like this delivered at a primary care level would be able to make 
better use of the social cohesion within communities and thus increase the social learning taking 
place through peer interaction, reducing the need for surgical referral, thereby reducing the burden 
on the healthcare system. 
5.6 Recommendations 
It may be helpful to make use of simpler measurement tools when dealing with participants with 
lower levels of education such as these. With the suspected confusion regarding the completion of 
the BPI as well a number of incomplete instruments submitted, it would be worthwhile to identify or 
develop other tools which offer a simpler rating system, but still evaluate the biopsychosocial 
aspects of pain. Based on personal communication with participants in the experimental group, 
there was perceived benefit from the intervention, with increased levels of exercise and reduced 
levels of disability being reported in conversation almost routinely at each session. The results 
however do not mirror this.  
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It would also be advantageous to ensure that a consistent research assistant or interpreter is used 
throughout the entire process to manage, as well as to reduce the possibility of the introduction of 
any errors or differences in how the tests or questionnaires are administered. 
The course material used in the intervention may need to be re-examined for use in future studies in 
a pre-operative sample, due to undergo their surgery soon. It may be more beneficial for those 
involved if it contains more appropriate information regarding surgery specifically, as well as 
perhaps placing more emphasis on explaining the difficult idea that nociception and pain are 
different and not equal to one another.  
The current study should be replicated in different settings with an optimised curriculum targeting at 
risk patient groups in order to thoroughly assess its merit for use in a pre-operative population. It 
may be useful to assess levels of social cohesion within groups before beginning so that should they 
be found to be low as was suspected but not assessed in the current study, the researcher could 




Chapter 6: Conclusion 
The current study was undertaken in response to a gap in the literature regarding the use of 
education and exercise based interventions to improve post-operative outcome in patients 
undergoing TKA. The efficacy of this intervention and those similar to it is well established in groups 
who are not due to undergo surgery in the near future, however as mentioned, post-operative 
follow-up was lacking [29, 95, 102, 115]. The aim of the study was to assess the effects of a six-week 
physiotherapist-led exercise and education based programme on post-operative outcomes in terms 
of pain and function in patients undergoing TKA at TBH in the Western Cape. The objectives were to 
establish whether participation in this intervention pre-operatively caused a significant change in 
post-operative outcomes in a group of patients undergoing total knee replacement as compared to a 
control group, with regards to the outcomes of pain, disability, HRQoL, physical functioning and fear 
of movement. 
The results showed no significant differences between groups at three months post-operative 
follow-up on any of the outcomes except for fear of movement. These results are in contrast to 
those achieved previously in people with end stage OA on the waiting list for arthroplasty [29]. 
Although fear of movement scores for the experimental group were significantly better than the 
control group at three months post-operative follow-up, these results did not translate into any 
functional change or reduction in disability. Possible reasons for this have been discussed in the 
context of the biopsychomotor-model of pain [152],as well as using social learning [155] and self-
efficacy theory [97].These surprising results suggest that changing beliefs is not enough when it 
comes to trying to produce behaviour change and postoperative pain and that there are several 
factors which need to be addressed to enhance effects. 
What is also important to note is that perhaps these results suggest that one cannot simply apply an 
intervention designed for those on a waiting list, to those who are going to have surgery. The needs 
of the surgical group are obviously different to the non-surgical group and need to be assessed fully 
in order to provide effective and meaningful interventions for these patients. Another notion to 
consider is that perhaps these interventions shouldn’t be conducted in a pre-operative population at 
all as the expected benefits of prehabilitation in patients undergoing TKA are not well established 
[169]. Instead, to improve social cohesion and social learning, which were identified as potential 
barriers to success in this instance, these interventions should be conducted at a primary care level 
with the objective of reducing pain and enhancing function with the potential of reducing the need 
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Appendix A: Course content (Workbook lodged with FHS HREC under HREC Ref 
378/2013) 
Week 1: Osteoarthritis, self-management and exercise 
• Pathology of OA 
• What is meant by “self-management” 
• Self-management steps 
• Action plans, goal setting 
• Exercise dos and don’ts 
• Types of exercise 
• Steps to success with exercise 
• An exercise routine 
Week 2: Managing common symptoms 
• Physiology of acute and chronic pain 
• Pain and flare ups of pain 
• Swelling 
• Joint protection, assistive devices 




Week 3: Stress management 
• What is stress? 
• Managing stress 
• Sleep management 
• Communication with your health carer 
• Relaxation skills 
Week 4: Eating well 
• Balanced nutrition 
• Dealing with barriers to eating well 
• Food safety 
• Weight loss benefits 
Week 5: Medication and disease related problem solving 
• Making informed treatment decisions 
• Appropriate use of medications 
• Link between a healthy lifestyle, good nutrition and exercise 
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• Communicating effectively with family, friends and health professionals with regards to your 
problems 
Week 6: Continuing as a successful self-manager 
• Recap of key components of successful self-managing 
• Action planning for the future 




Appendix B: The Brief Pain Inventory  
BRIEF PAIN INVENTORY 
1. Throughout our lives, most of us have had pain from time to time (such as minor headaches, sprains 
    and toothaches). Have you had pain other than these everyday kinds of pain during the last week? 
Yes  No 
2. On the diagram, shade in the areas where you feel pain. Put an X o the area that hurts the most. 
3. Please rate your pain by circling the one number that best describes your pain at its worst in the  
     last week. 
 0 1 2 3 4 5 6 7 8 9 10 
 No                Pain as bad as  
 Pain                you can imagine 
 4. Please rate your pain by circling the one number that best describes your pain at its least in the  
     last week. 
  0 1 2 3 4 5 6 7 8 9 10 
  No                Pain as bad as 
 Pain                you can imagine 
5. Please rate your pain by circling the one number that best describes your pain on the average. 
 0 1 2 3 4 5 6 7 8 9 10 
 No                Pain as bad as
  
Pain                you can imagine  
6. Please rate your pain by circling the one number that tells how much pain you have right now. 
 0 1 2 3 4 5 6 7 8 9 10 
 No               Pain as bad as 
 Pain               you can imagine 
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8. In the last week, how much relief have pain treatments or medications provided? Please circle the  
     one percentage that most shows how much relief you have received.   
 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
 No          Complete 
 Relief          Relief 
9. Circle the one number that describes how much, during the past week, pain has interfered with  
     your. 
A. General Activity 
 0 1 2 3 4 5 6 7 8 9 10 
Does not          Completely 
interfere          interferes 
 B. Mood 
 0 1 2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere          interferes 
 C. Walking Ability 
 0 1 2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere          interferes 
 D. Normal Work (includes both work outside the home and housework) 
 0 1 2 3 4 5 6 7 8 9 10 
Does not           Completely 
interfere          interferes 
 E. Relations with other people 
 0 1 2 3 4 5 6 7 8 9 10 
Does not          Completely 
interfere          interferes
  
F. Sleep 
 0 1 2 3 4 5 6 7 8 9 10 
Does not          Completely 





G. Enjoyment of life 
 0 1 2 3 4 5 6 7 8 9 10 
Does not          Completely 




Appendix C: The Western Ontario and McMaster Universities Osteoarthritis 
Index 
The Western Ontario and McMaster Universities Osteoarthritis Index 
(WOMAC) 
Name: _____________________________________________________ Date: __________________ 
Instructions: Please rate the activities in each category according to the following scale of difficulty: 
0=None,  1=Slight, 2=Moderate, 3=Very,  4=Extremely 
Circle one number for each activity_____________________________________________________ 
Pain   1. Walking                    0   1   2   3   4     
   2. Stair Climbing                  0   1   2   3   4 
   3. Nocturnal                      0   1   2   3   4 
   4. Rest                    0   1   2   3   4 
   5. Weight bearing                  0   1   2   3   4  
Stiffness  1. Morning stiffness                  0   1   2   3   4 
   2. Stiffness occurring later in the day                 0   1   2   3   4 
Physical Function 1. Descending stairs                  0   1   2   3   4 
   2. Ascending stairs                  0   1   2   3   4 
   3. Rising from sitting                  0   1   2   3   4 
   4. Standing                   0   1   2   3   4 
   5. Bending to floor                  0   1   2   3   4 
   6. Walking on flat surface                 0   1   2   3   4 
   7. Getting in/out of car                  0   1   2   3   4 
   8. Going shopping                  0   1   2   3   4 
   9.Putting on socks                  0   1   2   3   4 
   10. Lying in bed                   0   1   2   3   4 
   11. Taking off socks                  0   1   2   3   4 
   12. Rising from bed                  0   1   2   3   4 
   13. Getting in/out of bath                 0   1   2   3   4 
   14. Sitting                    0   1   2   3   4 
   15. Getting on/off toilet                  0   1   2   3   4 
   16. Heavy domestic duties                 0   1   2   3   4 
   17. Light domestic duties                 0   1   2   3   4          
 
Total Score: ______/ 96 = ________% 




Appendix D: The EuroQol 5L (EQ-5D) 
Under each heading, please tick the ONE box that best describes your health TODAY. 
MOBILITY  
I have no problems in walking about 
❑ 
I have slight problems in walking about 
❑ 
I have moderate problems in walking about 
❑ 
I have severe problems in walking about 
❑ 
I am unable to walk about 
❑ 
SELF-CARE  
I have no problems washing or dressing myself 
❑ 
I have slight problems washing or dressing myself 
❑ 
I have moderate problems washing or dressing myself 
❑ 
I have severe problems washing or dressing myself 
❑ 
I am unable to wash or dress myself 
❑ 
USUAL ACTIVITIES (e.g. work, study, housework, family or 
leisure activities)  
I have no problems doing my usual activities 
❑ 
I have slight problems doing my usual activities 
❑ 
I have moderate problems doing my usual activities 
❑ 
I have severe problems doing my usual activities 
❑ 
I am unable to do my usual activities 
❑ 
PAIN / DISCOMFORT  
I have no pain or discomfort 
❑ 
I have slight pain or discomfort 
❑ 
I have moderate pain or discomfort 
❑ 
I have severe pain or discomfort 
❑ 
I have extreme pain or discomfort 
❑ 
ANXIETY / DEPRESSION  
I am not anxious or depressed 
❑ 
I am slightly anxious or depressed 
❑ 
I am moderately anxious or depressed 
❑ 




I am extremely anxious or depressed 
❑ 
  







We would like to know how good or bad your health is TODAY. 
This scale is numbered from 0 to 100. 
100 means the best health you can imagine. 
0 means the worst health you can imagine. 
Mark an X on the scale to indicate how your health is TODAY. 
Now, please write the number you marked on the scale in the box below. 
The best health you 
can imagine 
























Appendix E: The Aggregated Locomotor Function Score 
Aggregate Locomotor Function Test (Score sheet) 
Code: _________________     Date:      
 
Flat, straight walk for 15.48m     Time taken in seconds _____________ 
 
Get up and go (15.48m)     Time taken in seconds _____________ 
 
Stairs Ascent (11 steps)     Time taken in seconds ______________ 
 
Stairs Descent (11 steps)     Time taken in seconds ______________ 
 
The tasks will be clearly set out for the participants, with the instruction being to do all activities as 
quickly as you possibly can.  
 
The aggregate score for the above tasks will then be calculated, and this will be their test score. 
 











Appendix G: Study information  
(To be explained over the phone and given to participants at the initial contact session. Informed 
consent will be obtained along with this.) 
 
The effects of a six-week pre-operative, physiotherapy led exercise and education intervention on post-
operative recovery, in terms of pain and function, in patients with osteoarthritis, undergoing total knee 
replacement in the Western Cape. 
Good day. I am a qualified physiotherapist completing my master’s in physiotherapy at the University of Cape 
Town. I am planning to work with the physiotherapy department at Tygerberg Hospital to do a study on people 
with arthritis in their knees. 
Why are we doing this study? 
I am interested in finding out if taking part in a six week course for people with arthritis will make a difference 
to your recovery following your knee replacement. The aim of the course is to increase your knowledge about 
arthritis, and to teach you some light exercises and relaxation techniques. To find out if the course actually 
makes a difference, we would like to interview people with arthritis, and invite them to take part in a six-week 
exercise and education course.  
Why did we contact you? 
You are currently on the waiting list for a knee replacement at Tygerberg Hospital, and are due to have your 
surgery soon, so this makes you a potential candidate for this study.   
What will you have to do? 
• If you would like to take part in the study, you will be asked to come to the hospital for the first visit. 
At this visit we will ask you a few questions which will help us to check if it is safe for you to take part 
in exercise. If it is not safe, you will not be asked to continue.  
• We will tell you all about the study and any questions that you may have will be answered at this visit.  
• We will help you to complete four short questionnaires (in English, Afrikaans or isiXhosa) which ask 
general questions about you and your health.  
• We will then ask you to do four short tasks which will show us how well you can do daily activities. 
One test will simply require you to walk along a straight path. The second test will check your ability 
to get up out of a chair and walk as quickly as you can along a straight path. The third test will look at 
how quickly you can climb up 11 stairs, and the fourth test will look at how quickly you can go down 
those stairs. All these tests will be timed so that we can figure out how easy or difficult it is for you to 
manage these tasks.  
This whole session should take about one hour. We know that this is quite a long time but we need to try 
and get as much information as we possibly can to see how well you are managing with your condition. 
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• We will then put you into one of two groups. One group will take part in the programme, the other 
group won’t. You have the same chance of being put into either group.  
• One group will be asked to come back to the Tygerberg Physiotherapy department at the hospital 
once a week for the next six weeks, to take part in the course which will happen once a week for 2 
hours. This group will consist of 12 people, who all have arthritis and are waiting for joint 
replacements, just like you. The group sessions will take place on either Wednesdays or Thursdays 
from 12:00-14:00. 
• The other group will continue to receive their normal care which their doctors have prescribed. We 
will still ask them to return to fill out the questionnaires and perform the tasks again after six weeks, 
immediately before surgery, on discharge from hospital after surgery, at the 6 week follow up and 3 
months after surgery. The participation of people in this group is very important, and will give us the 
information we need to compare normal care to the six week programme. 
Will you be paid for taking part? 
We will not provide payment for taking part in the study. We will give R30 to cover the costs of transport for 
hospital visits so that it does not cost you to participate. 
How does this benefit you?  
We hope that this course will help you to learn more about arthritis and how to cope better with it. We hope 
that we can show you the importance of exercise and how it may help you by making you fitter and stronger 
and making it easier to do some daily activities. We also hope that you can learn about goal-setting and how to 
achieve your goals, so that you can believe more in your abilities.  
What are the risks to you?  
We want to minimise any risk to you as much as possible. Our exercise sessions will be led by a qualified 
physiotherapist, who will check beforehand if it is safe for you to exercise. We know that exercise can cause 
some stiffness or a mild ache in the muscles for the day or even two days after exercising, especially if it is new 
to you. We will try to minimise this by checking what you can do at the start and then starting slowly. Each 
week you should get more used to exercising, and as you do, the physiotherapist will give you a bit more 
exercise to do. If, during the study, you experience a big increase in pain, we will make sure that you are 
assessed and we will act as necessary, either advising you to do a bit less exercise or to stop and we will refer 
you to the appropriate doctor for management.  
How will we use these results? 
The information (but of course not your personal details) we get from this study will be provided to local 
authorities, the local institutions helping people living with arthritis, to the scientific community, and to 
provincial and central government. It can’t be guaranteed, but we would like for the information we provide to 
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lead to changes in the treatment of patients with arthritis. We can also not say for sure that participation in 
the study will provide any direct benefit to you or your family.   
Will anyone know what answers you’ve given to the questions? 
At the start of the study you will be given a code which we will use instead of your name when storing all 
information. All the answers will be put together and no-one will know who gave which answer except for the 
researchers and members of the ethics committee. We will not give your name to anyone and your name will 
not be linked to any results.   
Taking part in the study will not interrupt your normal care at all. Taking part is completely up to you and 
nothing bad will happen to you if you choose not to participate. If you do choose to take part, you are allowed 
to pull out at any time and you may choose not to answer certain questions if you don’t want to answer them. 
If you choose to stop coming, it will not affect your normal care at all. Your chances of getting a knee 
replacement and position on the waiting list will in no way be affected by your decision to participate or not. 
You may continue to ask questions at any point during the study and you are welcome to contact either myself 
or my supervisor for any necessary information that you may need. Should you choose not to participate, and 
you are not receiving physiotherapy but would like to, we will refer you to the physiotherapist at your nearest 
clinic to be treated there. We would really appreciate your participation in this project should you choose to 
join us.  
What if something goes wrong? 
The University of Cape Town (UCT) has insurance cover for the event that research-related injury or harm 
results from you participation in the trial. The insurer will pay all reasonable medical expenses in accordance 
with the South African Good Clinical Practice Guidelines (DoH 2006), based on the Association of the British 
Pharmaceutical Industry Guidelines (ABPI) in the event of an injury or side effect resulting directly from your 
participation in the trial. You will not be required to prove fault on the part of the university. 
The University will not be liable for any loss, injuries and/or harm that you may sustain where the loss is 
caused by 
- The use of unauthorised medicine or substances during the study 
- Any injury that results from you not following the protocol requirements or the instructions that the 
study doctor may give you 
- Any injury that arises from inadequate action or lack of action to deal adequately with a side effect or 
reaction to the study medication 
- An injury that results from negligence on your part 
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An injury is considered trial-related if, and to the extent that, it is caused by study activities. You must notify 
the study doctor immediately of any side effects and/or injuries during the trial, whether they are research-




Appendix H: Questions to include or exclude patients telephonically  
(Using ACSM guidelines for pre-participation screening) 
To make sure that the information we get from you is useful for us, we need to make sure that we 
use a group of people who are similar to each other. This means similar in age, language and health 
status. I need to start by asking you some questions to make sure you fit into this group before we 
can have you as participate in the study.  
1. How old are you? 
2. Do you have osteoarthritis in one knee only? 
3. Do you have problems in any other joints in your legs? 
4. Do you have any other problems with your back or legs which give you pain? 
5. Have you had any accidents/ previous surgery for problems in your legs before? 
6. Can you read, write and understand either English or Afrikaans or isiXhosa? 
7. Do you have any condition which affects your ability to understand concepts? 
8.  Have you participated in any self-management programme for arthritis before? 
As we have discussed, this study involves participation in an exercise programme. We need to make 
sure that it will be safe for you to take part in these exercises.  To do this, I’m going to ask you a few 
more questions. 
Do you have or have you had any of the following? (Category 1 – immediate exclusion. Yes to any of 
these, stop the interview and thank them for their time. They are not eligible for the study) 
___ A heart attack  
___ Heart surgery   
___ Cardiac catheterization   
___ Coronary angioplasty (PTCA)   
___ Pacemaker/implantable cardiac defibrillator/rhythm disturbance   
___ Heart valve disease          
___ Heart failure            
___ Heart transplantation    
___ Congenital heart disease 
a. Screening question (see specific responses) 
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• Do you have diabetes? 
 IF YES, Is it controlled by medication?  
Yes – OK; No – end interview, thank you but not eligible 
• Do you have asthma other lung disease? 
 IF YES, Is it controlled by medication?  
Yes – OK; No – end interview, thank you but not eligible 
YES to 2 or more of these 4 following questions not eligible, end interview, thank 
you for your time. Yes to one of these, perform exercise assessment. 
1. ___ Do you have burning or cramping in your lower legs when walking short 
distances.  
2. ___ Do You experience chest discomfort with exertion.    
3. ___ Do You experience unreasonable breathlessness. 
4. ___ Do You experience dizziness, fainting, blackouts.   



























Please read the attached information sheet for the study titled: The effects of a six-week pre-operative, 
physiotherapy led exercise and education intervention on post-operative recovery, in terms of pain and 
function, in patients with osteoarthritis, undergoing total knee replacement in the Western Cape. 
Our hope is that this study will help health professionals to better understand whether a six-week course for 
arthritis, which includes exercise and education, helps people to cope with their condition more easily.  All 
records will be kept confidential and all information given in questionnaires will remain anonymous.  
You may contact Sara Warren (investigator) on 0727844298, Dr. Romy Parker (supervisor) on (021) 4066431 or 
the UCT FHS Human Research Ethics Committee on (021) 406 6338 with any questions regarding your rights 
and welfare as research subjects on the study. Your decision to participate is voluntary and choosing not to 
participate or withdrawing at any time will not result in any change to your normal care or prevent you from 
receiving any services to which you are entitled.  
I,      have read and understand the above information sheet.* All my 
questions have been answered and I understand what will be asked of me for this study. Knowing this, I have 
chosen to participate in the study. I am aware that my normal care will continue with no interruption or 
change and that I may withdraw from this study at any point without experiencing any unfair treatment or 
change to my normal care as a result.  I also know that I do not have to answer any question which I feel I do 
not want to. I give permission for the researchers to contact me to interview me. I commit to attending the six 
(6) week course if I am placed in the course group and I understand that although the researchers will do their 
best to make sure that anything said in the intervention group remains confidential, they cannot guarantee 
this because it rests on the group itself. I agree to come to the hospital and participate in the study from now 
until three (3) months following my surgery. 
           
Participant      Date      
           
Department of Health and Rehabilitation Sciences 
Faculty of Health Sciences 
Divisions of Communications Sciences and Disorders, 
Nursing and Midwifery, Occupational Therapy, Physiotherapy  
F45 Old Main Building, Groote Schuur Hospital,  
Observatory 7925 




Witness       Date 
           
Researcher      Date    
* By agreeing to participate in this study, you do not give up your right to claim compensation for injury where 
you can prove negligence, in separate litigation. In particular, your right to pursue such a claim in a South 
African court in terms of South African law must be ensured. Note, however, that you will usually be requested 
to accept that payment made by the University under the SA GCP guideline 4.11 is in full settlement of the 
claim relating to the medical expenses.  
An injury is considered trial-related if, and to the extent that, it is caused by study activities. You must notify 
the study doctor immediately of any side effects and/or injuries during the trial, whether they are research-
related or other related complications. 
UCT reserves the right not to provide compensation if, and to the extent that, your injury came about because 
you chose not to follow the instructions you were given while you were taking part in the study. Your right in 
law to claim compensation for injury where you prove negligence is not affected. Copies of these guidelines 




Appendix J: ACSM pre-participation screening 
History (mark all true statements) 
You have had: 
___ a heart attack 
___ heart surgery 
___ cardiac catheterisation 
___ coronary angioplasty (PTCA) 
___ pacemaker/implantable cardiac 
___ defibrillator/rhythm disturbances 
___ heart valve disease 
___ heart failure 
___ heart transplantation 
___ congenital heart disease 
Symptoms 
___ You experience chest discomfort with exertion. 
___ You experience unreasonable breathlessness. 
___ You experience dizziness, fainting or blackouts. 
___You take heart medications. 
Other health issues 
___ You have diabetes. 
___ You have asthma or other lung disease. 
___ You have burning or cramping sensation in your lower legs when walking short distances. 
___ You have musculoskeletal problems that limit your physical activity. 
___ You have concerns about the safety of exercise. 
___ You take prescription medication(s). 
___You are pregnant. 
 
If you marked any of the statements in this section, consult your physician or other appropriate 
healthcare provider before engaging in exercise. You may need to use a facility with a medically 
qualified staff. 
Cardiovascular risk factors 
___ You are a man older than 45 years. 
___ You are a woman older than 55 years, have had hysterectomy or are post-menopausal. 
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___ You smoke or quit smoking within the previous six months. 
___ Your blood pressure is >140/90 mm Hg. 
___ You do not know your blood pressure. 
___ You take blood pressure medication. 
___ Your blood cholesterol level is >200 mg/dL. 
___ You do not know your cholesterol level. 
___ You have a close blood relative who had a heart attack or heart surgery before age 55 (father or  
        brother) or age 65 (mother or sister). 
___ You are physically inactive (i.e. you get <30 minutes of physical activity on at least 3 days per  
        week). 
___ You are >20 pounds overweight 
 
If you marked two or more of the statements in this section, consult your physician or other 
appropriate healthcare provider before engaging in exercise. You may need to use a facility with a 
professionally qualified exercise staff to guide your exercise programme. 
 
 
___ none of the above  
 
You should be able to exercise safely without consulting your physician or other appropriate 
healthcare provider in a self-guided programme or almost any facility that meets your exercise 





























Appendix N: Other relevant data and analysis 
Table 6: Least pain scores and differences between groups from recruitment to three months post-









Least pain     
Recruitment 4 (0-10) 4.5 (0-10) 4 (2-8) U=85; p=0.79 
Post-intervention 5 (3-10) 7 (4-10) 5 (3-7) U=33; p=0.01* 
Post-op 6 (0-9) 6 (2-9) 5 (0-8) U=36; p=0.077 
6 weeks post-op 3 (0-9) 4.5 (0-9) 1 (0-4) U=19.5; p=0.01* 
3 months post-op 3 (0-9) 5 (1-7) 2 (0-9) U=32.5; p=0.07 
* indicates significance 
Table 7: Least pain score within group changes for both groups from recruitment to three months 
post-operative follow-up (median and range used as measures of central tendency and dispersion) 
 Experimental – p=0.03* Control – p=0.02* 
Least pain Median Range Median Range 
Recruitment 4.5 (0-10) 10 4 (2-8) 6 
Post-intervention 7 (4-10) 6 5 (3-7) 4 
Post-op 6 (2-9) 7 5 (0-8) 8 
6 weeks post-op 4.5 (0-9) 9 1 (0-4) 4 
3 months post-op 5 (1-7) 6 2 (0-9) 9 
* indicates significance 
Table 8: Pain right now scores and differences between groups from recruitment to three-months 








Pain right now     
Recruitment 5 (0-10) 5 (0-10) 3 (0-9) U=70.5; p=0.33 
Post-intervention 6.5 (0-10) 7 (4-10) 6 (0-9) U=33.5; p=0.01* 
Post-op 6 (2-10) 8 (2-10) 5 (3-9) U=43; p=0.18 
6 weeks post-op 3 (0-9) 4 (0-9) 0.5 (0-4) U=20.5; p=0.01* 
3 months post-op 3 (0-9) 5 (1-9) 2 (0-8) U=25.5; p=0.02* 
* indicates significance 
Table 9: Pain right now score within group changes for both groups from recruitment to three 
months post-operative follow-up (median and range used as measures of central tendency and 
dispersion) 
 Experimental – p=0.03* Control – p=0.03* 
Pain right now Median Range Median Range 
Recruitment 5 (0-10) 10 3 (0-9) 9 
Post-intervention 7 (4-10) 6 6 (0-9) 9 
Post-op 8 (2-10) 8 5 (3-9) 6 
6 weeks post-op 4 (0-9) 9 0.5 (0-4) 4 
3 months post-op 5 (1-9) 8 2 (0-8) 8 
* indicates significance 
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Table 10: Differences between groups on the individual items of the PIS from recruitment to three 
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Table 11: PIS individual item within group changes for both groups from recruitment to three 
months post-operative follow-up (median and range used as measures of central tendency and 
dispersion)  
 Experimental – p=0.04* Control – p=0.01* 
Interference with general 
activity 
Median Range Median Range 
Recruitment 7 8 5 8 
Post-intervention 7 6 6 8 
Post-op 8 5 7.5 5 
6 weeks post-op 6 9 2 7 
3 months post-op 5 5 3 8 
Interference with mood Experimental – p=0.46 Control – p=0.13 
Recruitment 6.5 9 4 8 
Post-intervention 6 10 5 9 
Post-op 6 5 5 7 
6 weeks post-op 4 9 1 10 
3 months post-op 5 9 1 8 
Interference with walking 
ability 
Experimental – p=0.046* Control – p=0.035* 
Recruitment 6.5 9 5 8 
Post-intervention 8 7 6 8 
Post-op 8.5 6 7 5 
6 weeks post-op 4.5 9 1.5 7 
3 months post-op 5 9 4 8 
Interference with normal 
work 
Experimental – p=0.03* Control – p=0.09 
Recruitment 6 8 5 9 
Post-intervention 8 5 5 8 
Post-op 8.5 3 6 9 
6 weeks post-op 6 8 2 3 
3 months post-op 6 8 4 7 
Interference with relations 
with others 
Experimental – p=0.29 Control – p=0.04* 
Recruitment 5 9 1 10 
Post-intervention 5 10 4 10 
Post-op 6.5 10 5.5 9 
6 weeks post-op 3 7 0 10 
3 months post-op 5 10 2 10 
Interference with sleep Experimental – p=0.21 Control – p=0.04* 
Recruitment 6 10 3 9 
Post-intervention 7 7 5 7 
Post-op 7.5 6 7 5 
6 weeks post-op 6 8 1.5 5 
3 months post-op 5 8 2 8 
Interference with 
enjoyment of life 
Experimental – p=0.1 Control – p=0.13 
Recruitment 6.5 9 3 8 
Post-intervention 7 6 5 8 
Post-op 8 10 5.5 8 
6 weeks post-op 5 8 1.5 8 
3 months post-op 5 10 4 8 




Table 12: WOMAC Pain sub-scores and differences between groups from recruitment to three 










Pain subscore     
Recruitment 14 (4-20) 14.5 (10-20) 12 (4-19) U=45; p=0.03* 
Post intervention 14 (6-19) 16 (6-19) 14 (10-18) U=68.5; p=0.43 
Post-op 14 (4-19) 14 (10-19) 13.5 (4-17) U=49.5; p=0.35 
6 weeks post-op 9 (0-17) 11.5 (1-17) 8.5 (0-14) U=38.5; p=0.17 
3 months post-op 10.5 (3-17) 12 (4-17) 6 (3-14) U=35.5; p=0.11 
* indicates significance 
Table 13: WOMAC Pain sub-score within group changes for both groups from recruitment to three 
months post-operative follow-up (median and range used as measures of central tendency and 
dispersion) 
 Experimental – p=0.08 Control – p=0.05* 
Pain subscore Median Range Median Range 
Recruitment 14.5 (10-20) 10 12 (4-19) 15 
Post intervention 16 (6-19) 13 14 (10-18) 8 
Post-op 14 (10-19) 9 13.5 (4-17) 13 
6 weeks post-op 11.5 (1-17) 16 8.5 (0-14) 14 
3 months post-op 12 (4-17) 13 6 (3-14) 11 




Table 14: Self-care scores for both groups from recruitment to three months post-operative follow-
up (median and range used as measures of central tendency and dispersion) 


































































































































































Recruitment Post-intervention Post-op Six weeks post-op Three months post-op
Experimental group












Recruitment Post-intervention Post-op Six weeks post-op Three months post-op
Control group
None Slight Moderate Severe Unable Missing
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Table 15: Anxiety/depression scores for both groups from recruitment to three months post-
operative follow-up (median and range used as measures of central tendency and dispersion) 

































































































































































Recruitment Post-intervention Post-op Six weeks post-op Three months post-op
Experimental group












Recruitment Post-intervention Post-op Six weeks post-op Three months post-op
Anxiety/depression scores for the control group
None Slight Moderate Severe Extreme Missing
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Appendix O: Demographic questionnaire 
 
Code: ______________      Date: _____________________ 
Group allocation: _____________________________ 
Home language: ______________________________ 




Telephone number: __________________________ 
Cellphone number: ___________________________ 
 
Which area do you live in? __________________________________________________  
When were you added to the waiting list? ___________________________________ 
Do you use an assistive device? ____________________________________________ 
If so, what do you use? ___________________________________________________ 










What is your highest level of education? _________________________________________________ 
Are you currently employed? If so, what do you do? _______________________________________ 
Any other useful information gathered from the patient’s folder: 
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________
__________________________________________________________________________________ 
